Gene list
Applied filters:
COG category: Unclassified
Organism: Mycoplasma synoviae 53, 53
Gene type: CDS
Number of genes found: 140
Show UniProt / TrEMBL protein name | View in Fasta format (DNA) | View as list | ||||
# Mycoplasma synoviae 53, 53 >MS53_0254 putative phase-variable hemagglutinin MLHWDGFMPKIVIDDYVADGYDVANNSENNRAQHEAANRPLLEQWFKVNQ DKLSLVADQLTKKLGEEKFKNMTLSNPTISWDEVEFSNKGSNKVYLTPKV TFNLAAKDGYALAEGSTTTVTLTIRVLYKDSNLTRNVLSTQGAYYTATPS DNATTIEKVNVYLNYTGPNIELNAELPKVGSQENTSLNGTSNVTDNFNNK FNKLLIRYKAETSLFQKIINYVNKFDPKFPAKFVTNSINGVTITKVEKNK KQKREELRPGNLEDLLYNNNVFLQQMHGDSSAVYFAVTALTNDKWLNTVL VRIPLTKFIRSVAPFAAAAPTEEASGDQAQADPQATQMGTQAQS >MS53_0176 hypothetical protein MIIKNMHLESLLNSLILFNKMAKKNKIVFSVCGQSLNQLYFSKELQAPFE IALSFENYNKLLFDKNFKTSDYKLNVNDNPLPRFFLDNNEFWINLLIPSE TDLVLSSKTKKLIYKINQSSKHQKIISLVDYLNSNNPNTWAYLYFDSASQ KLKVKAVYKINPNFYKVIKLNKNLSLPYLNYFEENLK >MS53_0598 hypothetical protein MKFFSETVKLEKNKWLEAQRDSLAALEEIKKKQPSLTINQSEILDFAFMN LSLQMTDEHWKQKLDSNPNFVVYKPLLQNHKKTVDSLEVEYKTYYLDDLE KFSFDDSYKSELKLESNYEELLQDYIEKFVQNYEFHLPKKDAPVAAGDYC KVVFYEKEEQKASERPVFVYAGKSKDQLAFEILSLELNKPKAIDFYGLKG YVEVLEAFEVKHMPITEENVKLLNLPFAQTLADLKNVVYKQVRENIVANC LYYYGNDALNFYTLNNKDIAKIEFEKDLEAATSQMDQSKNPNFANYTLKK FSVEVMLRQKWNIDVTEEELHAELQIVNSFINPPKNSSVNWPRLYHVVFC KKLGLRLLKKNFPEVYNEHKEFVRIS >MS53_0329 conserved hypothetical protein MKQKIFISLSAIASIGLGLSAIACSGANQSGNSGSNNPVNGQGELQERRA NSLLGANPEGRNNAFQQDKKEKIVLAANFLGSTAQANALVELANAYNSDP DVKTKYAGFFKPVEVEQIGSTYSDGAKKVAQYLKAKNKSAFYNLVLNHPS VAAEIAKSNMLLSFNDSLGRENLDTDVSLFSSLFTDANTNTENIKNPSTY ILPVMKSTMVSSVNGPVLYYILKTMVDNGATLSQDKDTQDFYNALMKTSS SDLEFIKQKWGNPVDNARTLVTSANLTISKDMFNKYEDLLNFAMVAQKLF TNSANNQNDLHIVGMDFPTVTLKTSVFSIVGNDYSKSLEAPSKVAGTNKV SYNSLSTTGSPAQVAARTVYKKLKDAAGSGAVVLQPLGQYSSGKQIYHNF ALSIGSTAGYLYNFIDDTAASALRFTFDSSLDKFSFDDNDNPAASNYNNR YFVSFKQGSEYLSASAKDKNKTNEVLLSFGKNNNALIASGGKTASGSDFH MVDAKSDQALKTALAEVTKDGNQENYKLLILRQSSNDNNQLATMKAKVMN LASKDTKKELVYAGVAKGGSSSRPRNAVLVFVKTSNNNFVKTDLEKYGKQ LGASVSQLTSANSLNKSELVVMNAPGKWNKNSTKNVAFLRGPSLIGIKAN EEDDNATKAFVHWLVTNKKTYTFFSGKNNEVSASPSEFFQRQMSYLMPIA GFETSTTKFNNGFLDNALEVFSSAAKDPQNWTTYEPPGSELGDLFDQALD SAFRNLGNQALVNTSADKLQSFEAFVNSFTEIFGSSN >MS53_0412 hypothetical protein MSIKNNSKTKLKIFIKRNFDEIFYLSALFLVSTILLITIVFNYSSIIFGY LLSGLMIYLWNKYNKLFYYVFFQKVNFKYSKWVKIMIFLFLKKALVFITL GALIYFIVTIDVNAVINSEISGNKVIKFMHPINIFAFIVGIIINMFIYFL ALYLHAKKNSK >MS53_0493 hypothetical protein MNKNNERENNLNSASQETSQNFSNEFDNKTQLIDLEKIETVPLKSKKEIV KLIIEKNQFTEEDKLAFKKQKRIYWMAITSISAIALLALFLLLSVWFQFF >MS53_0585 hypothetical protein MQFLNLKGLVKNYNGIVCIETNNSDLFIRKLFEFEHAENQSSININNNKY SIKDFIIIDNLTKYHDLYNFNSKGLLNQWINDLDFENQKIANEKLVLEIK NLLNNKIGFEFVSIEENNSKYLKYLFNLENDKFIDNKSLIKWMENQKYNN QKINLIIKNFDFVLINELIKFSNNFNIIVLTNDFFKHINNFDYIESVAFT NEDLNRIVSIEEKDSFEYFLEEIFQDSIRNIEKFDFFSQNNKDLIKKSLK INFF >MS53_0402 hypothetical protein MKKFEFLLLGSATLPLMAVAAACGAQQEKVEEPDFVHETLTDAEKIAFQS AAGSNLRTMGRMRLVVRAALVNNDKTLVSRFTTLAGEDATKKAAVETFKT EWTGKWGALFGTLSDGDKNVFSGENKYANGTATLAEYQTLKTAFTEKAKD LLASVAKVIKALGLGDLSDDYKTYLDSANVSALQTRFNYTGALVPDSSTL NDFERFLESIVGEDTSKDQSNPTPTGNMVTVLSGLEDNAVFSKTVMSLVA LLTDRMVRLVEGAEAAKVLVSTGTATAEAAKETYLALRKYDKWPASTLKT RGTALSTPVQALEPVLKNVETVLSPLFAEGGKGKSLVDTLKAKESKTDKE TMLLSRLESLANLAKANSELEKLSLLVYKDGVALDYEAAVLKSVKTYADF YAKVGLSWQWALNVLLWANPAKDLVTYFTASGLADKFADKKADLEAVVAE VTKLNVAATLANFDKFKAAGDTLNLGLFNQKARALTSHLQAMLAATKK >MS53_0118 hypothetical protein MVMNFEQKNNLNSLHVDVDKDYKFLISSKKTQGQFYGLVFMFFSLAFSVF VALTISIYHSVFNAIVNGVDNAFTRFMKEKPFVVYGLVLGLFVAYFIVIW FLRKFSWKSLIFSYPVVVLFFSVMISMALVVYSINPDWNRETTSYKNPPI TVPLVLMFAPMLVLFFLGVFSYYGLFDLTKLMRVSGFLLAVFLILTVIGI FAVGPVYGTINVAISIIGIAIISISTIYTFNRILTDSKNLAFFSKHEFIA RAAGYGIELFISYANILWFLIRIMMKFKK >MS53_0438 conserved hypothetical protein MQKNNLIDSWKRLYTQHYLDVEFFKEQSALEKNLSLPKINFYSLEFNSDA ENNLSNLNLFTLLGILKSFCELKNVKNKHIFMHFDENISPFLVRKAISLI NYNVENIYLFNSENNAYKLDLANDFVVYQVSKAFNLDYVIFLQKNKVNNK YYLKIYKKNFLLSTLEYEEILEHFKNSNHDFVFKENIDNNKKIDINKIIE SAILPSEINLLKKSQWTNDSLIVSMLVASNLDEKILTQALEKANYKVIKY TWNLHKKLSKWKKYSLQKFLNNSLNKSDVLVILDANHKLKLVIRTKKGFR LLSDDEIIFIYVSYFYLSLKKLNLLNQNFIYIPYNAGPIVHKILTNYKIN YKYIDQANFTNVLLAYENGFYSSGQSFNNLQSNYAFLINFCSILNAYKDS NNLINLKYKTVKKFASLFWQTTKKTKFSEDGVETLIKNTKQFEKVGKYLK LEKIETINYLSKNYHYLFDIYYQYKYKKTTHKIKINLTYNLISKKLEIKM TSEKNDNFWIKIKEFFINKYMLMIFNFLIKKYKNNIKKTETYYEISKS >MS53_0174 putative P60-like lipoprotein MKNKFKKLLTLSAIMPVSAIAISCGTTFDDPEKVAQDKLLNSNNAKLAAE KFWLDQSIASLYGSTSAELTSNEKYKQEALNAYKVYVASQNLKDPFYLWN QVNSWNLKGLFNESAELNSLKKYKSSVDETSYWLAYNKDETDVKFNTQKL LLVLKYFELNDAKSLQKVNQNYALQKDNYDNNQFNLIDYVLNKKLVQSWS YDNQSDKNDVFSTLTRSIQNVSDYNNLLKNTPALLNVASQELLFNANNSA AEVTMGGFANLKALPAEVKLSYDLQSLLQVTEAKKLSGFYNYQNNTLVPL SNTSLEAPVFVSRDGQLLKVSYFNQVAPIKDTIDGKDVLSFNKTAYASKL FNLEVNLAAYDDKLYNTAKSAFVALGYLLEVNNETLKEKLAGEDFVAK >MS53_0211 putative phase-variable hemagglutinin MKPKTCPKMLIKFWDGFMPKIVIDDYVADGYDVANNAENNRAQHEAANRP LLEQWFKVNQDKLSLVAEQLTKKLGEEKFKNMTLSNPTISWDEVEFSNKV SNKGYLTPKVTFNLTPKEDYKKASDSSEKVTLTIRNLYKEANSDTNVFAT QGAYYTATPSDNATTIKKVNVYLNYTGPSIVLDADLPRVGEQENTSLNGT SNVTDDFNNKFNKLLIRYKAETSLFQTIINYVNKFDPKFPAKFVTNSING VTITKVEKTKELRPGTLDDLLKNKNNVFLQQIKGDKEAVYFAVTAIASNN WLNTVLVRIPLTKFVKPLSVFTAPVVTPPAEEATGGSQTQEARLQPAGYS NSDSFGSTEQTPPSTT >MS53_0416 conserved hypothetical protein MTNHFPFFQWKKYRKISLFSGILILLIALFVTLSNWVLDVRGLNNSLSKL SASARQEIIYADAAPSVLATLWKNTLTFTHMSNYALGIIWILFALYPTKW HSQRAAYLITVYITITFLVYWGLIFPQIFKGGIGPFKTFLTTLVHAINPI IGFSLITYNRKRITISKGTFFGLIPIMVIYYGFALVSFLIGQNTADNFAG LKKSPDSDVLINHQNGQKLVDNVIYEFLNILHPFFYQGDNLAIVVAINFG LVVGGILFTLLLGFIWKVSLRLKWDRENKAHLVY >MS53_0386 putative lipoprotein MKKLKFLFLSGSVILSAAPLAVSCGADEVKPADKQIIFATAQGDTWPLMV ALKPMIEYYNRTFFEDPDFVPVYLHTQTQTQTYSELRLITDTITNIDANS ENIPNIILSNQTGAYLMKSRGKLLDLKENGLNIRFSQKIQDSHSILAGQS LDTKQLFNVPFDIADTDSVVFNLDIMNKLFELIKSNGGKVDDFDLVQKAK AASETGSDIPKRSPFYALKAKSSSAFDGYHVTEDTFKTFKGIRDFAKKVY DATDFDQEKTGELKLSANVLSIDYQEDVFRKELQSLTKDSQRLWNLETTS DANQPTKINFENLKNSESEASKTFVKLWNEWKAALAERKVKEGGTNDIRF QSIQFKKNENADWGSYDIRKYSSAISYAASVGSNATQQSYLSVAQFLSGV QEPEETEEYKSWASHDDVFMKSQLLLAKENANKAYWEGGSSIVAIQSSDE DLNKGTSKFLNWLYTGTVIGRKTFEEDEEVPNWMKIAELSGYILPSESAV TQENLDKMIASRDQLISDWRKQLKAFKERIASGESFISGKRESIKLSIDE KLVKANRLNSAIVTLESLLKYTNNDDVKEANNVGDYNTAVLVDILKDDLL NLNTPTKESNVFESSTTGEEQLAKFQRLVRKL >MS53_0226 putative phase-variable hemagglutinin MPKIVVNDYKIVADGYVANTDEVKKEADKTTNQEKLQNWFNDPANWEKLA EQLTKKLGKEKFKNMTLSNPRITWDEVEFSNKLYLTPKVTFNLAAKNGYA LAEEQDASAKEISLVVRVLYNRDDESTIQLPTQGAYYTAAPSDANADNPA SAIKNVNVYLNYTGPAIMLNADLPKVGNQANTTINGTSSVDSDFNTQFRT LVFNNNNNVTSLMNAVVNYVNRFDPKYRAMFVTNATDGVTWAKVQIQKVK GQKDREELRPGNLEDLLYNNKVFLQQVQDDSNAVYFAVNGVTSKGWLNTF LIRIPLTKFVRPISVLEAPQQEETQEDGEEMQQGNEDGTQAGQTDETAGS GTPQASTPQTMPNSSQ >MS53_0457 hypothetical protein MLSKIAPKISEIPKKNMKYFRNFFIPLSLETLNNSKSLEPTNAPENELES GDINSETIITQTPIKTKNITRVNIRLILLFF >MS53_0236 putative phase-variable hemagglutinin MSNAFFYLKVNQKLTWKYKKAPAQAAPATQSDSIAAESTSATVRVAMSEE AAAEAKTQTPAPTPAADLASTVSYLKSLNDTLKAATDALNGDNPTTKTAY YKADAGRTLYWDGFMPKIVVSLLTTKLANQEYDASVRQGGVVFWKTRNGE ILDVWFAANQDKFTLVANQLTRKLGKDKFKNMVLSNPRITWDELTIPEGT ILTPKVTFNLTPKEGYEKATGSLETVTLTIRNLYKAAAPNTNLFATQGAS SPAAPRGATVNDANVKAKVNVYLNYTGPNIELDAEAPTVGSQDNTSINGT SNVDDAFNTAFRGNPSRGLLFTNRYANPLLKSVINYVNKFDPKYRAEFVT NSKNGVTITKVESDTQLRPGTLDDLNKNNVFLQQIQGDTEAVYLPVTALT SDKWLNTVLVRIPLTKFVRPISVLEEQSVQD >MS53_0175 putative membrane protein P80 MHENKKIKKVSNSQATRKKAAIATLSLLSVGVILAIAVPLGVTTNSVTVI SPVDDSSTAFTFKGPNSSDGSQKLTVGSVTKSVQGSEAQVKEEISDVTKK LVFYLYDQEYKASVEQQRVYNASLALGQSARNDIALSSLEEIKQKQTKVV EDLKRNYISVYGFQNWQKQFTETLSTDPKYSGAKDEAEAIENLTYNEIKT YAEARFKPEFVNTTRSEINKLASRDIYKVDANGNEISSNGQRQVLIKSGE RVNSFYQDGSNYFLNAANNNLATAFLTKSFVSSQKDPSEILKSYFDANDL HVVTSVDLPGKLSSPVTNAITLDADAKAKFINLAKYWSVKNTNSQRQILS GSEILKQLKSATSYFPTPTEALSQSQITVNQGNYQTFLNTLTLTKGDSYG TSGLQSIESVFQNGTEQGLSSIWSKVLGSTLNASNLPQVDLSKVFDFENI RTNDPSAYSRFSTLLTAAKNATSDQDAFNKTKELNQFIESYLTNMSNAEF SSLLVRQYTNQLVKNVGGNNLVSFIYAIKDMPNAYLVVSKDKISIQQYTN FTSFDNFKEFVKNTLYSVAQGNKNIFNLPQAVSQSQNDNVILAHMLNDAD FVSYLKTKENPFSKDKSNYSDEDIAKIKQENASIIAGNKSKMQIQNFTSV SNLINNSLVSQNSYNFGVKDGVARIISGFNGSTPTYLGNSESAQDLIVKV LISK >MS53_0213 putative phase-variable hemagglutinin MLQAIINYVNKFDPKYRAEFVTDSKNGVTITKVQKDKQKRDRELRL >MS53_0247 putative phase-variable hemagglutinin METSRSVTAAKAVKDDAQYNSVDATLKTTLEEKYTAATALLEDGTKLKNL DASSNLDTTKATLESAKTALDAAVAAVKPELEFQKTKTSAAAKVTELESL VNTALKTELQRQVNALTKDHATEATTMLANLTSLKDSLTSLQDLVSKGLA MQVNYPRNYYDADNKSAFDNALLKASSVFPAFVWTTNSIMVETPEGQLPN PRAWTKAREKSEFKLQNFVMAPAQAAAPTTAQTSPSAAASAIVRLAMSEE AAAEAETQTPAADLASTASYLKSLSDSLKTETDKLNGDTTENKTAYYKAD ADRTLYWDGFMPKIVLEGFDSSWAQNSENERKIREWFREASNWAGLSDQL TKKLGAERFKNVVLLNPQIIFEDVRLLTRGSVKFPKVTFRVAAKDGYQLA NGEGKTTTLELKIRVLYSSSNPNALLLPYQGASSSAAPREATVNDANVKS KVNVYLNYTGPNIELDADLPTVGGQKILQLMEHQM >MS53_0037 hypothetical protein MTIKNSKMFYRIFFRKFSFPIIYCLIVSIFYFSFILVSFFAIYNNWSTDN HPGKVDWIIKNQPGTTEGIPTSEQQKVFYSLAFYQQGYFLYFVLIFIYII PVSMFSHYLKIFYKSDYYKRIILLNGNKKTFRYIGLYLVIFWFLIFLIIN LLRILGMDYIFKFNIWLQDAKKIRSGIEPYVGIRLDPNEIFHYYSYQIPQ SHFTENFNNRFLTYIIGCISIFIASILFTLFLTFTSVWIKILFLAMLFVS YVLGIYYGADFNFYLEKDITVEYAKSVNFLWPISLLNPYVTLPLILKFYI SSKEFDIWIYFPLIMQFLFFSILLATTLVIRKRLDRHIFL >MS53_0064 hypothetical protein MNNTNFKVNIVGDLSQKDFKFQLELSRVWTNNLFSISIFNTLDKNKYALD LALNSKDVLKDVQRDLNQIEMPFNLIQLSYNKLNNIFVTIYNKNYPNERI QYQILLSTFKKVKLNLKSNKENIDYKIPYQYLFNFNSNKTWYLDKTFTNI KWKFHNPSKQRSLGEIAQILFENDDAFYFETRRNKLITELPVVNSASLLA KPLFDTQFELAIESNLNNLGFIQDANDIKFKKLFLNFDDYISIDNLNQRV EINGDIAPTKKFTVPRFFIGTLRYSLIFENSNFEIITEKILKFEQDEFID YSRPKIKIKDITDDVNFSLLRLKYKINLSKIINFISLEDDQLNFNYLLRN NLIYKKDENE >MS53_0075 conserved hypothetical protein MDFSNIEINLTKTNLENKEVNFSGNQLRSYLKNLLDKILVQSYLNLKIVI PDLYDFLWNHSIEEKANINLALIIIKYKTFDWFFNACKKNNIDVYFTIDY KKKEKVLKNIQNFLKIKSSDLYKKSKYMLMDFFLTKEVEINSLFIHDDLY NLFREIILFYNHWNPKGFFIENSTALFDDNKFKKIVNYQSYEKIDIINKL LKNIKKEFKCEIYGIESSIIKIKNFYKVSAFDHHFYRGQHLTFRKLIKNF VDCKKNSVSLIYDAKNILSSKQVKIFKYLNQINTISKLAIMNFDYFSFVY LYPKNENEFIQTFSHKLLYNHTNNLLFSYSNNGFFRSKLKNKNALKIKAL YVNILGVKYFKIYLNFENEKYLLFCNLSEKIIKINTSKFKNLFVDDSQKD NLLLAFESDFFETN >MS53_0042 hypothetical protein MLSTMIVAPSAIIASTVNKKEANAFFGKKTEIIWIQKGEKHVDGNDYKTS HDGRVWARDYFWSSDEVFWRGVAEARVERVLFDSTLPNRVVLGVETWVEG SGRPSVSSSISISQSSGLEASLGISSNPTEKGRSFSYVFEDTNTSSVHYS YSGRIWSWSYVGISTNPFLKKRIK >MS53_0454 hypothetical protein MLFFCSSFSFFFFFFRSYFFCYASFNWSCFFFYLSSFCRSFSCYFFCCCR SHFSLWFFFCFYFSFSSWCSFFNSRFYSFFSFNFFNFYFFSSYCFSSSCF CWFSFSCRFNFFFNYCFFCCFYFCASSWFFNCYFFSLGFANFCFWCCNFF FYFNCRSFFNCFCFSYRSSFFTRRFFYFFTCNFFNRRSFFNFYFFRSNFS CFCFWNSL >MS53_0450 hypothetical protein MSNVNIKNNNYDKNYLIENERFLSRQISKIVSLDFDRSENIAFNDIANSF SKKNSGIKHIVNFCDNIYNLNLDYLLILTPSDLKISILACLDFVLGKQDF NEDKKIKFIFIDESESSSSIDEKIDYFFEKVRDNRVGLLFIDEIVKNEKL KKVGQNLIIKFNKFSSHFIVKKYLFYVGKRSLFSQNYENLNLLKENILFS SEDIHNDYNIFSENVLIFLALKGINISKLIDGYEIEVNKIFFKTSEMPKS LDLAVSLYEARNELFVEEDTQKIFFVAYDDFLINISKLFSIKYQKLLSKY RAFCDYLHFPRQIYSVGQIVLNGAKNIFMIYLTINNKIFDFQFSSNLNDN YGQDFENYTLNEMKRHSKDVFDNNFLSLNPNSKSIEINLENNKEQTLGEL LAILYWSKIFYSMISSQKAF >MS53_0476 hypothetical protein MITMIIIYNINMSNYILYKRKNPKQIYIALGISKGYGKGIGNLVGLGYWE EIKEKYSLQNIDDLKQIARLVPVGENKIEVKTNFFNYLTRHLLKQI >MS53_0220 putative phase-variable hemagglutinin MGADKFKNVVLTAPTVSYEKVTVGKYTWKNPKVTFNIQAKPGYQLTEPTT NSKQISLTIRVLYENQASTQNLLTIQGASSSAAPSGSSVDDANVKANVNV YLNYTGPSIVLDADLPTVGGQENTSINGTSNVTGEFNTAFRGNPSKGLLF TNRYANPLLKSVINYVNKFDPKYRAKFVTNSINGVTITKVEKTKELRPGT LDDLNGNNVFLQQIQGDTEAVYFAVTAIASNNWLNTVLVRIPLTKFVRPL TEFQAQSATTPTQEGQTTQGQENSAGSGALGSTTGTQTPSGGSSQASGS >MS53_0390 hypothetical protein MFLFAIFLFFISFVRIDFYKPALINFDNDEIYISNFSSEKLQPNQYIKFS YLSNEEVFQFETKIEKILDSKIYIKDARIASELKSKNINLLNISMFFEEK VLWKYILKI >MS53_0265 putative phase-variable hemagglutinin MFQAVINYVNKFDPKFRVQFVTNSINGVTITKVQNTKELRPGTLDDLDKD NVFLQQIKGDKEAVYFAVTAIASNNWLNTFLIRIPLTKFVKPLSVFTAPV VTPPAEEATEGSQTQVSTPQTMPNSSQ >MS53_0246 putative phase-variable hemagglutinin MNGTSNVDGTFNTKFKDLVTSDQRTASLFFQAIQKYVNTFDPKYPAKPIS DQKNGVTWARVVGNALKIGELSETNTVFVQQMQNDTKAVYFAVSAIASNG WLNTFLIRIPLTKFVRPLTEFQAQSATAPTQEGQTTQGQENSAGSGALGS TTGTQTPSGGSSQASGS >MS53_0552 hypothetical protein MEAEVFVRRLVLLELHLKETILSFISPYGERLVLISPTTGEIDWTISGML VSIPNAIGPSPGSISDNWLLSNFCNWFILIITSHNIK >MS53_0234 putative phase-variable hemagglutinin MALYWDGFMPKIVVDDGYVENTEENNKENNKNTNQQKLEAWFKANQDKFT LVADQLTRKLGEEKFKNMTLSNPTISWDEVKFSKGNVTKLYLTPKVTFNL AAKEGYEKASDSSETVTLTIRNLYKEANPDTNVFATQGASSSAAPRGATV NDANVKAKVNVYLNYTEI >MS53_0260 putative phase-variable hemagglutinin MNYTGPNIVLDADLPTVSGKENTSINGTSNVEGTFNDKFKELLVDNNRVP REFLSTVINYVNKFDPKFRAQLVTDTNGVAITSVQSKKELRIGNLNDLLY NKKVFLQQVHGDSSAVYFAVNGVTSEGWLNTFLIRIPLTKFVRPLTAFTA TPASAPTQTDSGTGAQTQPEAQS >MS53_0210 putative phase-variable hemagglutinin MSDQLTKKLGAERFKNVKLTYKEVTFSTNAVKTPTVNFTVAAQDGYTLDN STNEISLVVRVLYNRDNESTIQMPKQGASPSAAPSNSSVNDAKVKAKVNV YLNYTRPNIELDAEAPTVGSQDNTSLNGTSNVTDEDFNAAFRGLLFTDRY VNPLMQSVINYVNKFDPKYKAAFVTEKNGVALTSVQSGTQLRIGSLNDFL YNNKGFLQQVNTDTKAVYFAVNGVTSQGWLNTFLIRIPLTKFVKPLSVLQ AATDSSQNAEQTGETQGSQPEAQSQ >MS53_0059 hypothetical protein MAISYKQATSKDLNLSFDFEITYFEMSKFVIDIKNTLRPLEFNEKYCEWF IEDLIYFLKSNGYNFRFDLGLLELVNGKNLKKLVNKKPVDLNDLEFEEIK YFLEKKITNFDVRITK >MS53_0233 putative phase-variable hemagglutinin MWFTSGSVTKAKEAKDDAEYSKVTDTIKTTLEEKYTAVAGFLTEGSKLAN LNADGTLATTQSDLESAKSALDAAVAAVKPDLDFQKTKTIAAAKVTELDA LVNTALKDELQRQVNELTKEQADQATTMLANLTSLKESLESLQDLVSKGL AMQVDYPQKYYDADNKADFDAALLKASSVFPAFQWTAESIMVPALEEDAL PNPRAWTKAREKSEFKLQNFVMAPAQAAPATQSDSIAAESTSATVRLATG TEEAAEDSESSEAQTAPTADLASTVSYLKTLDTDLKAQTAALNGDTTTNK TAYYKPINGRTLYWDGFMPKIVTTALPTTVAPMNREYNESPTGGHEFWKG RNKQVLDAWFAANQDKLSLVAEQLTKKLGKDKFKNMVLSTLTITWDEVQF SNRLYLTPKVTFTLTPKEGYEKATGSLETVTLTIRNLYKEANPDTNVFAT QGASPSAAPGNPTEPNNAIVIKNVNVYLNYTYI >MS53_0238 putative phase-variable hemagglutinin MPKIVVDGYVADGAGANKAQHETKNTRLLQQWFDTPANWEKLSEHLTKKL GANKFKNVTLTNPQVSYEEITVNSNTWKKPKVTFNIQAKPGYQLTEPTTD SKQISLTIKVLYENQAYTQNLLTIQGAYPFAAPSNSSVNDANVKAKVNVY LNYTEI >MS53_0314 hypothetical protein MTKLPKEKILEALTSFIGYKNKGISIYQLELLKLIKNKKVIANKLSIERD FIFRWWYFLNIDLDIVSKKFENNKITENTRKLAKSIASIDVSKYSLKEEL NYILDNYILVNSYDNVSEIKNIFHLIIHSI >MS53_0609 hypothetical protein MMKKIKFSFKDLNTNYFFLKCLMLVSAHFLYLADWIWNGVGIEHFTTICT YFFGLILTHLFLFVFYRNKKNEELKFDKFWNSKQKKSTLLFLVFFVFVFL IFSRLNLIWSDPDTFPYSNSFHRTLYNFWAIFWDGILVFNSFIVIASVLF LTLLSDYVFKLIYYTKPKYNAVEKSKAKLKNFAVIYLGVVTSLWIQIAML LKHIYYKETATLAQIVNPVFLLILLVGFALFVFVYFNVNLNNLKITKDEK SQIFKFSKNLYYWFLWIVLAWFFISWIPYTYYFLVTNYQVIRGFKERNSI DINPSSWNFVHMSYLAFNSMLIIMPSSLLLTCAFSFLSRKHWSYKLK >MS53_0285 conserved hypothetical protein MSISASCGSSNGSINESNNNIGGVTDNSSIKDRRLNALLGANPEASSNAF QQVEKDKIVLAMTFSQGGAQAKALNELVNAYNNDAELKAKLGNIFKEVTV NNVGSGYGEGAKKVSQYLEAKNTDNFFNLILNYSPVGAILANSNMLLSFN DPNGNPDLDTDISLFNKDFVNSNATTENIKNPSTYILPIMKSTLVSTINA PVMSYILDTMKAKGVTFSDDVDTKNFVAEIDSKGQPDRSQIQKQWGDPVD NATELLKGFQFSKKIFNNYEDLIKFAELAQKLFKNTQDNQNDLHVLGIDS PTSTFQNSVYSLTGYRYANSLEATSKKNGVNTVNYNSLTTTGSPANVAAK TVYETFRSAVATQGVVLQGPGQFTSNKQIYHKFAMSIGSTAGYTHNYIES VEGTINFNFSQYSGFNFKASTNKSDRNNYNRSGFLTFGLGLNGLGRKYRT NYTSDQIFLGFGSFKNGLAKSNVTLKSRFDIKSIDTTNDASIQAAIDKIK NDTSNWKLLLLQQSDSSKTQEFTDFQTVVKNAASQNSSEIIYGGVAESSN SKNPQKSLVVFVKSSNSNPVKADWEKYIKLLGGTAEEQTSSNTLNKNELV VINAPTKWNENSAKNSIYLQGPSLIGIKANEVDDAATRAFVHWLVTSKKE YTFFKDDSKSTVTATPSLFFQKQMSYVMPTSDFQNSVSDKTFDSGKNSRT DNPFLENALQVFKNAAKDQANWTTYESPGSEKGDAFRNSVESAFKNLINQ AANGTQVSQLQTFDQFVQSFRDTFGSNNN >MS53_0435 conserved hypothetical protein MKKSWQDAKANIKRNNFLLLAVAFLLGAVTNAMISSFANDVVLSYIANAF GIKNLQEWKLENGILIGKFLGTVIQFAIVMVLLFFVLFLFFVIKNNYVEH KNRKNPPQPVVKPLTVDELILKELQQLNSNITKNQLSQDMQTSLSALETS ARKTSSRSASSKKLNKK >MS53_0215 putative phase-variable hemagglutinin MHKIVVSLLTTKPANQEYDANPRTTSVTFWKQRNGEILDVWFAANQDKFT LVADQLTRKLGEEKFKNMTLSNPTITWDEVKFSKGNVTKLYLTPKVTFNL AAKEGYGKATGSLETVTLNY >MS53_0227 putative phase-variable hemagglutinin MKKVTVNSNAWKNPKVTFNIQAKPGYQLTEPTTDPKQISLTIRVLYENQA STQNLLTIQGAYPTAASSDANADNPASAIKNVNVYLNYTGPAIVLNADLP TVGNTDNTTINGTSPIRDAYLATKVKALLNKTANQNYSTELMQAIIKYVQ TFDPKFKTSVDPNASQSTYRAWVSWMETRERDMQRNPALVQVELKNPTNV FLKQIQKKIKVKNQNKNKVNHKLKNNNKIKVSFKI >MS53_0008 conserved hypothetical protein MIYLIMSIKRIAYFGMYLGIILGLSLIPYIGLITIGPVSINIITIVIIIA SFHLGFFGGLASGAFVGLGSFLAALLYGRILFIYFDIAFLPRLLVGALIG VIVIKIKKITIWKALFLGLLAALANTVLVTAFLFLHNAISTIAFIGESLK GFVFWVSLISVNALVELLVLGALSMFLFKFYIYLCNKTNQEKAEKLLKY >MS53_0367 conserved hypothetical protein MDLILETLQKRLNSDKRKLKFYEFLDRFIGLFITFINIVILIIASLALDK LTSDSEFNKNNLFSQNTSLLLLIAFTIVLIVSFFLNIVIEIYKINQRYDE YKKVSNTFSYLIVKYRTKFINEKDLIAQTNKLWEKASKKTKIQIKRYLIN MVKGTN >MS53_0374 conserved hypothetical protein MKVRSKLKKILMVTAFLSVSILASSCNIFDTLSSRQKKDEKKDDKLYLNK NGDPEDQDDQSKKPVVTPPVTFKPENPSKDPISEKPQEPDAPEAPSAENN FNINTDIKNWDQKLSNVQLQSIYNNNPQLTRFNFTKAPENTKFSSNEEYL ESIFKRTFSINFNYSTQTIAGTAWVLDYHYDKNNPKEITLYLATNFHVAT NLRTANDYEFYVQNSPNLERVRSVDLRFAQDWRNPDTSYITKRYTGRNMP RNIFLAKNFMDQEVSSSYNDGGGYYADFSVIEWKFKISDFYSNSSFFINT VDPSLDLWVKKIESAAGEVKAAVDKNLGIDGGYLNTKAHEGYTSLDYTTI QSTYYSDLSKTITNEVRYPQTVNEILEFQKNVNNTFTNYIYAFRPEYWFF GGYPLIPNDGFVPTFNIDYDNLTNLGFNKNDYNPDFKIIYTLNNTKNTDQ KISFNNEPTYAFYGTAYETFQKIKIHGGISGSLVLNEQGIPAGVLYGSFV NDTEKITRKDGSTLTLNNALMIPFAQQKDITYTTFDGQSHTIYAYNLVDG TDKAKFPHQIDSFREKLIEVYGPNYKTKLFPNGVGVFDGPSNHDINSEKF KA >MS53_0501 conserved hypothetical protein MMKNFTEKVGKFFKSSFPGKWTTRKIVFVAILIAVSVTFTIISVQIAPFA GISTYKVAFIGLPVKISGFIFGPVIGIFIGLVSDLISLIYIPPTTYNPLY TLVVVMNGFIPGLFSWFFFRFINYAFGADFRTKLYKSKIQLYSTSYLVAV ANPDSEKEANYYASKIIYYNNKKEYIKRFGTINLIKNINLIIALMILSII ILFEIITIGFLIPDAYLVKSPVKNRWIIVALITTGLIMMMSLCIYGKFKI KSSRYLVMVPIIIFSAVLEIVNLPILSFADLFALGNSSIKDIFLWIFQHV FLAPVKIWFNIIIIYYSFSIISKLVNKTLIYLEILAVKNETK >MS53_0242 putative phase-variable hemagglutinin MASTASYLKSLSDSLKAETDKLNGDTTENKTAYYKADTTRTLYWDGFMPK IVVKDYQPAGHGNNKDTNETANKTKLQEWFATSSNWEKLSEQLTRKLGSD KFKNVTLTNPVITYEKVTVNTYTWKNPKVTFNIQAKPGYQLTEPTTDSKQ ISLTIKVLYENQAYTQNLLTIQGAYPFAAPSNSSVNDANVKAKVNVYLNY TDI >MS53_0208 putative phase-variable hemagglutinin MPKIVVSLLTTKPANQEYDANPRTTSVTFWKQRNGEILDVWFAANQDKFT LVADQLTRKLGEEKFKNMTLSNPTITWDEVKFSKGNVTKLYLTPKVTFNL AAKEGYGKATGSLETVTLNY >MS53_0570 hypothetical protein MNNMENSKYKKLLSLLENASFSKSLVGVSPSEIALFINNLKSELLLLESS YNELSAQNKELKEQNENLVLENLKLKADLKLK >MS53_0269 putative phase-variable hemagglutinin MRDVNVYMNYTGPAIMLNADLPTVGGQENTSINGTSNVDGDFNTKFKKLL VNVVGGSFTQTSLLQAIINYVNKFDPKYRAAFVTEKNGVALTSVQNNTQL RIGSLNDFLWNNKGFLQQVNGDSSAVYFAVMGVTSEGWLNTFLIRIPLTK FVRPISVLEEQSAQDQTQESQEGQENQEQGSTTQTNTESSGTGQSSDLTE VSA >MS53_0540 hypothetical protein MFSYFWFFVFLIINLVSLWPIDYLYQYNSWGYKGNSSNIYEIPWQKEFSE SDLEFFGHERPPITLVPSNLSSSLNNDNFIDNGFFYNELLDQYFFRPKQL FGSYIKKWNNIYFKYKPFDGILIDNFFYLNNKYFSHIILSFLSFFTAIVF VSASFVLNKWILSLIWIFIFISLILDFSGLLNRIDFDREGLYSISYKEAH DFIGSELNFKKFLVKIPFSLFNPYSLLDVFTNFHFLTKKISMAWAFPIIF ISIFNFWFLNFIIRTMKRNSEYSFL >MS53_0237 putative phase-variable hemagglutinin MSGSVTKAKEAKDDAEYSKVTDTIKTTLEEKYTAATALLEDGTKLKNLDA SSNLDTTKATLESAKSALDAAVAAVKPDLDFQKTKTIAAAKVTELESLVN TALKTELQRQVNALTKDHATEATTMLENLTSLKDSLTSLQDLVSKGLAMQ VDYPQKYYDADNKSAFDNALLKASSVFPAFKWTAESIMVPAPEGAALPNP RAWTKAREKSEFKLQNFVMAPAQAAPTTAPTESESRDGSGGGTSAAASAT VRAAMSGEAEGAQEEDSEAASPTAEASTPTADLASTVSYLKTLETELKTQ SEALNGDTTTNKTAYYKADTTRTLYWDGFMPKIVLDNFDSSWAQNSENER KIREWFGDATNWEGLSDQLTKKLGAERFKNVKLTFKSARFSTDPAKVPTV AFTVAAKDGYTLTTGDNASATEISLVVRVLYNRGSESTIQLPTQGASASA VPNKTTKVNDENVLRTVNVYLNYTGPSIVLDQAVPAVGITANTSLNGTSN VTGDFNTKFKKLLVRVLNGGHAESSLFQAIINYVNKFDPKFRAAFVTNGT NGVTITKVQSNTQLRIGTLDDLVKNDRNNVFLQQIQGDTEAVYFAVTAIA SNNWLNTFLIRIPLTKFVKPLTEFRPTTPTSTSSDTQQQGTAQTQSNQGS >MS53_0290 conserved hypothetical protein MKIIIFCFNKLKIVKLYDRINQLFDLKKEVYMYEDFRKNFIKTIKNERYS NLLKLFSVINKLTYIWMENNNV >MS53_0070 conserved hypothetical protein MIKVKKNKIILLFGIASVALVSTAAISATVVKINSSYLSNQNAFAFNRSR SLELIDRGRAESRFNSNTDNNLEVPQPKKDDPIKPTIVENPPIVEEKPLV VLKPEPPKEEPIVVVAPPVQTPPQSNSSYDGSIINIQTITSTVSEKSDWN KPTGKRLSAALQKQAREAIEKAQKAFNDVFSKLKPNADGTVKFTDEQKEE LAKSLGVSTTNTKEYWYFNRFLKNFEEGSIAKDIMVHRDPSTAQANRDMF LHAINNVDYDFYFSINNIPYIKWEYGDDITIGGKPPSDAENVVVQHQINL NKKRFLSSDSKWRRYSPQMIADNDYFGWKQEDITSKAAQDIGISDTSGIK ISKYTPDQNNATVTDKSTVRYALTLDASNPNAYAAVIRNLNLMNQHNYKV EVFNVKHLGVDKSQDFAAVFRAMPDTIKLLNLFFDDTNTDALSGLKDKKI QSLGLWTTKNQLDENWGIDPYVLKNVENIEYDYQNSQSGDYPRGAEIAGS IIFRKLRFHKDDTIPQIQEGLKIALIEKADQRAFQGYWGSGSWPSELDFS NVIAVKSLKGFTFGPANDLVFKKLTLFNDTFNYVLSASDLADSGFEHMLF RDTKPSEIDFSNQGSTFNSYQIYIPGNTSDLKPNWVPQLQGLLYGGGRTF KKTIYVDNQDMVQRLSKSGVPGLYGFSVQVKPNGYDPNKNEASLDFSS >MS53_0499 hypothetical protein MNNNCNNKIKKVIMKKVNNFWKKLTAAKTKAIQKQNEASKSKKQESLIEM RLEEINNAILAYEHNVVDLDSKEAQMALPWYKRQLFLNLLGAGVTILLMV FLLVLAYLLGGIV >MS53_0156 conserved hypothetical protein MFKFKKPLNSKSRKTKEAQYSKEQLKYQDFVYKNYFEILSQAKDSDEKFL SYEQFVNQFYLKLNQKDKISEFNKLWKASYDSFFQKQQVVFDDFVLAWTR NERFSLHDLVPYVSLSEDSNVLSTDLSAKNNDKTNLVFKHLNNFLKDYLF EKLKVIEIFPNVILFLDENSKFKLLFDKSVVENER >MS53_0355 hypothetical protein MMRTMLEIAIEVISKDTTRHFTFEEIFQRVESELAEVWATKFVDEKNSYN DVRVRKMGELYRILTVDRHFKHLQDETWKSSTYKIKN >MS53_0231 putative phase-variable hemagglutinin MLQTIINYVNKFDPKFPASFVLNTNGVALTSVQSGTQLRIGSLNDFLYNN KGFLQQVNGDSSAVYFAVTAVASNGWLNTFLIRIPLTKFVRPLTEFQAQS PTAPTQEASGDQAQADPQATQMGTQAQN >MS53_0258 putative phase-variable hemagglutinin MLYWDGFMPKIVVKDYQPAGHGNNKDTNENTNQQKLQNWFNTSSNWEKLS EQLTKKLGADKFKNVVLTAPTVSYDDVSTAISTDSEVRIPKVTFTLQGKE GYKLQTTDGASTTLSLSIRVLYTSENQTENALKYQGASSSAVPNRASSPN DETTIKTVNVYLNYTDI >MS53_0613 putative ABC transporter permease protein MALLIILFSKDIMWNLFKETFLSLFKNKITIIGLTILVFLSTAVFVLLND ASSSIKKEYSRYTKQSKLHDITVDLNIPNSGSAYNDGYYINSLDRNLGGS FYDRPIHYIKSDYKTTSNILDINNIKDEYINLSSFVDDSNYVNKYLAKDD FLRFYNIYDPNSTSALKLQLNFNQPQKTFTLPEDYSFQVYNKVNNAYQVD FNNFVINLNDEIHFDKTYKLSDIATITFDNSKAIVSQLSTLFINVVSKQA TFDILKGRQWVEEKSGYRVTMNDLVKFLKLTKTSQNNFIYNLNLANASDA YSNLNSSSETNDIFNAALKDTFTFNLLSSKRLDFKNPTSIIFRKATSYKV PNVIAAQRENIEYFERKHYTTTYDKDNADKWLGSYKIVIDNLKDQNNGEI PKEFSDFSYWYKNVSVYFIRYDNNGRLDEQNKEKVLDFNSFVSLDEVKNT KLSIGPLDDQYPNTFFYNYLLKEPQTIEQIEKFSNITTQQYNNLINPDIL SNTFNYIKNQAKKVTQNSIVKYVEKKFGKDNLGLRQTVTVESVDNSGNKS VFNFINLGNANNEINGVKLNVDKPFYESQDSTALSTLNNQDLASYFKTRE LDPYVVQTLLLNAKHNFSSDRDYIIPEFDYWNVTYTKNTSNTVENLSNVK IYKLANFIGDNPKPNSEYNKFNGYGIFSYGDDFVLVKAVYDDDGKITHWV NADVVPSFNDVVRGGDIERFFRQRNLTLELQYINPNGWVKVDNLFSNIVY LPFYFRAPKPDLIAEALNNNSIEKGMQEIQKALLNTDLYKKGFITTNEIF VLIASATKVANDNNFAKIYAEGNINLNIVPKMVYQLIYELSHNPTGEYVS KILTSFLTTAKQYVNTKEGLAKEIKNLSSIFSIFGFNEILQFLSLDALTK IIENPSKVIDGLLQIVSSIDFRNFADKIKEFLDTEYDKVTTINEIDYTRK FSLYEIGTWLLESIDQKRFKDGVNTIIDSINPSGIIEYVKQIFGPILGNS FGELLNKLDAFKNTDTQYKNLTTGIKELVSLLDFNTLRSSLAEATEIHTF QIENSLIDPITKKPFTKIENFTAGVINNADVVKSLLRALFSVPGSDKTFK DIIIKMLNISSKGQVIQISNDQSLIIPADDPDKLGLFDLINLLGNSQQSF SESKVEEKNGFTYGSDLFSNIITFLILHEKDSVLNFRNLNNTEKFIAANV FRWDSKSRVTQKDIAAEIQKWAKIVKLFEYRPNANRYSKELSLSNLATYS LNFTSTNNNNLFWQTTSNLIRQLVPIAEPTKFNYVKDGYQSMILWWDILF SDEKISYQRKLDFAKDLLKLANEPSVIDSFNSFDLFQPSAENIIQHKKTN FGVSRSIANPERMRELFFTKSGSRYTNIYLQKLADKYPEFREFIENNELL ITQEFSYLASSDMYVRQGEDSNLDNQVPLKYKGLRSNLADNFLNGIASNN LIRDNLDVIQYILKVGYSNNIGGINPVFLSLLGISNILIDPVLRYSNPQY LIWALADTSSVNLNQDSVISNLAYFIQNKLVNFYNLINGNSNTLNVLLNN LFKDYPSINPINEYDSYQTIAIDNDFFEKLKEKTDADLENNLFLGINFTD FLLNVINSITSLNAANNVLVFNQNSSYVAKANYAWLQQNNKKIYSGEIPD NPIKMLALLNSLPEDNILNVNGVKFIIIGQEITADYLYPVIDEENLQVDT KSQGIIYVNQNGFDRIRNSYRNNVVKEYVVSKIPGETTDEQKSEIRNNIE NYVQETIDDSAKIQRTYLTNELDGINPERSLRVRIIDSIISSINKSLIAL TGILIFFVTVSVIFIIKRYIFNKNKVIGILISQGYSPWEIVFSMTTFSIF IIFFGGILGYVVGFTSQAAVIHVIKNYWTLPIVTLNFSWVSLLVTLMIPF LAITVLIYSITISSLRFKSIDLMSGVYEVKLGRVQRIFSSLFKSKKITTK FSASLIFNSFWKLFSFGTSIFLTSIVTIFAFTATTVFDKAINETYKNRLY NYKYDLKTPTVESNAYKTFNGSTLDNQLYVPLGHSSEINSYAGDYFRPGF SNSINTNFANGNPEYNDPHVLTQFSLNIRINGGVSVDPFNLIFNSLPDSQ KNKIIVIRNIIGKELEKTQDNLVYNSNNEIDISKTSKINKVGFFGYIPDN LVIQNGKFWYFQYNDAKNEYERVQITTGAYRNEYRQFLINGYKKLYEDPK KTQDFLISFGGIYLDNRFDETYTYAQAIFNDNSINLYGYRPDSKQIQVYD NNVNILKKINDEFDANPDLNEPIPLIINEVARYKYLLQRNQIITLKIENT TDRFKEKFDKEINPNRELSDNTYKFKIVDISKTYINTEFIIPHQAANLIT KLDKLNFGEDTGPFNGILSKNEIPSLLLSSASLYSYSNFWGVVAAIDTNS MSRIDKVALFNSLFGSKLTNPNDFTEGVLKTNGYSDFEIAKFINPNFNQN DRNAIYDNYHQTINNPDGAINKFLAAYNDMPYVIVASNLDAKNIELSFTT ITANTVKVIITFVSIIFFITSIVILIIFSTILINENTKNIAIWSILGYSN KEKVKMFFGIFIPFILVAFLLAIPLAIAIMQIFSITLTYVASIAIPSMIN AVNIFATLGVVLGVFSITSVILWINMNKIKAVDLLKGK >MS53_0240 putative phase-variable hemagglutinin MALYWDGFMPKIVLEGFDSRWTNVNDNKSKLQTWFNTKANWSNLEDQLVK KLGSEKFKNVVLSQPNVTLETFTWNRQTWGVPTVTFNLATKEGYEKAKNS TNTIALKIRVVYNSNNTNEILFPIQGASSSAAPSGANTANHTKTIKDVNV YLNYTGPAIVLDATLPEVGKVDNTTTNGTSNVTDDLNTKFKDLVTSDQRT NCITIFPSNSKICKYLWS >MS53_0214 putative phase-variable hemagglutinin MTIRNLYKEANPDTNVFATQGASSSATPNNASQANDATTIEKVNVYLNYT GPSIVLDADLPQVGTAANTSINGTSSVTGDFNDKLKKLLVSVLRGARSIF IITSNN >MS53_0203 putative phase-variable hemagglutinin MSDQLTKKLGAERFKNVKLTFKEASFSGDDIKTPTVKFTVAAKEGYTLTT GDNASATEISLVVRVLYNRGSENVIQLPTQGASASAVPSNSSVNDAKVKA KVNVYLNYTGPSIVLDETHPTVGATPNTSLNGTSNVTDDFNNKFNKLLIR YKAETSLFKAVINYVNKFDPKFRAQFVTNAIDGVTITKVQNTRELRPGTL DDLVVKNKNNVFLQQIQGDTEAVYLPVTAVTNDKWLNTVLVRIPLTKFVR PISVLEAPQQEETQEDGEEMQQGNEDGTQAGQTDETAGSGTPQASTPQTM PNSSQ >MS53_0244 putative phase-variable hemagglutinin MQTAPAAETPAADLASTVSYLKSLNDTLKAATDALNGDNPTEKTAYYKPV NGRTLYWDGFMPKIVLTDFDKTWEQNSENERKIRKWFDNAANWVGLSDQL TKKLGAERFKNVKLTYKEVTFSTNAVKTPTVTFTVEAQDGYTLAEGQDAS AQEISLVVIVLYNPDNESTIQMPTQGAYYTAAPSDANADNPASAIKNVNV YLNYTGPSIVLDEALPTVGKQENTSLNGTSNVTDDFNNKFNKLLIRYKAE TSLFQTIINYVNKFDPKFRAEFVTNSINGVTITKVQKDKQKRDRELRPGT LNDLKGNNLFLQQIKGDKEAVYFAVTAIASNNWLNTFLIRIPLTKFVKPV SVFQATTAAPTQEASEDQAQADPQATQMGTQTQS >MS53_0255 putative phase-variable hemagglutinin MLIYWDGFMPKIVVSLLTTKLANQEYDASVRQGGVVFWKTRNGEILDVWF AANQDKFTLVADQLTRKLGKDKFKNMVLSNPRITWDELTIPEGTILTPKV TFNLTPKEGYEKATCSLETVTLTIRNLYKAAAPNTNLFATQGASPSAAPR NATVNDANVKSKVNVYLNYTGPSIVLDADLPTVGGQENTSINGTSNVEGT FNNAFRGNPSSGLLFTNRYANPLLKSVINYVNKFDPKYRATFVTDSKNGV TISNVTNNVQLRPGTLDDLDKDNVFLQQIKGDTEAVYFAVTAIASNNWLN TFLIRIPLTKFVRPISVFTAPVVTPPAAETTETQEAQGDSASQSSPQTML NSSQ >MS53_0315 hypothetical protein MVFYLIADRYNNNQDLYQPTQGPYNESNSSKWVEFKITGLNKINVEDSKN DLLEKFNLSIKENVNHSLIANLIKEKSNDQSWFEDKTSEDSLFNALSFQF LETLLCLFKNFWFL >MS53_0209 putative phase-variable hemagglutinin MPKIVLDNFDKTWEQNSEENERKIREWFDNAANWVGLSDQLTKKLGAERF KNVKLTFKEASFSGDDIKTPTVKFTVAAKEGYTLTTGDNASATEISLVVR VLYNRGSENVIQLPTQGASASAVPSNSSVNDAKVKAKVNVYLNYTGPSIV LDETHPTVGATPNTSLNGTSNVTDEDFNAAFRGLLFTDRYVNPLMQSVIN YVNKFDPKYRAMFVTNAIDGVALTKVQNKKELRPGNLEDLLYNNNVFLQQ VQDDSSAVYFAITALTNDKWLNTVLVRIPLTKFVKPLTAFTATPASAPTQ TDSGTGAQTQPEEQS >MS53_0341 conserved hypothetical protein MKKLFLWEIHSDKVSLSESIYIDNLNYSNIANYMYNLYGQEMHNNLAKMS QKVSEIKAEENQKINFVVFDSSFFAQNLNSKKFQVSLSKREVLNSYQEFS SENILDLVDKKIYAFLEENKINYVGKANIFSYVTLGHSQEDSLFQVEKSY DNFPKNTDFETINIFFSVAICEDQVFYNKYKKILEFLSFDNNFVFYKESL LASYKAGQKSKKQNYFLLKLNQNSSEIVLRNKNNVIRHKNLFSKLSSKVN LKAKNQQLKFLNNNLNLDLNSSDLTFLKNNLSDFAKNLVDELSYLPIENL EISSENVHLANIMATLLKAQKTSYSVESIFNLNQENSFEKFLLNQAILNS SIINSNELKVENQTVTTNIKPNLNKRWFSFNLFKYFSNK >MS53_0063 hypothetical protein MTFLFLLILAGASGSAIYFLYQNDWKLKKDKASDSDKRFEFTSQENVFPD LDAEYFQKYIKLNSQNKEEIKQEIVLPIVSDVLSRLKSAEGKVEFDYTVK NTKNIEIYFKYKNGSNYQTKAYLVYLD >MS53_0495 conserved hypothetical protein MDFLKNGALLYVVLGFLIFGLVGWILFTYIRDKINKKKIHLAGVELDKLT KKYLAKFDVEINEVIAQNKRYLEKFVVSVGEYKMGELTNFSRKKVIEILE DSDFKNYVLENPKYAELVKNLSELKDVKSNMWESKALHNLTYFSNELKKL TSVTLTEEEEREIKEKVALSYGDNLRKKKKTS >MS53_0157 conserved hypothetical protein MNVKSLVNKRESYTKIKKIVESDKNITLINILRLSKQNVFYFERSLQAKY YIESLAKRYEIKHFLILQKQLKILSKLSRVKSIWVYITEEEKFATNSYQR HERNMKKSIDFKRDFLVVIGKRANEFAIKHKAHVIFSHDKNDVEFLVKIL PKFLQNYLKTNGFHNLNFVINSSKLKEAYLSVLPLNKLNFKIERNLQNKV ESVDTSKLKIYPEIKEFINSEFESYLTYVSLSLLSESALISEKYKLVALN KTLNDLDEKLRLLNIRIEREKRELEVEQISILFKKKDLLHSSSIKKEGS >MS53_0419 hypothetical protein MDFNNKLNQRINSTSDMSYVNYENLQVLKRRLTHTKNLIITGLVFTLVGV IILVVGGSMLAADTSGFASISIMFLGGLLATVVPIVFKVYYTGRVWSLRW EVENKYLTNDQETYHQKADAVSALITAKVLVSISWIALWLILDFVAIFNL LKARNILDTLSKN >MS53_0189 hypothetical protein MNLKNTNYADAYKVPSTKSDNVKIAEARLNLEQRDPKQGFVCNCTILLSQ HYGWQHIKNQEQLIKSVLDKAILGETLSRTEQELLDSLAKDWKTT >MS53_0192 hypothetical protein MHKYRKDGLSQSKAFFYCLGLGLIGGEYFYLKLKKLALIKLALAFVGATI IFVTLVVLANTQSPVLSDETKKAIDLKTANVFNQFTDKHQNTQALLPAYV VGGLLIASNVVWTIYNAVLIHNGEFKDNKKQKISQWTETQESYLEHLLTK SENWRH >MS53_0365 hypothetical protein MKPKKSQQDLSQETNFELLREITEKQQIILKKHRVSYGVWVFLNFLSVFI TSAIIILNLYAIRYNPRPDETMSFFVAIAILSATITFLVSIRTFFAISDK KEKLNYIIAENQNYIEQLKKSIKRKKNKTSGEPEENQNNTIEIKFNLDK >MS53_0249 putative phase-variable hemagglutinin METSRSVTAAKAVKDDAQYNSVDETLKTTLEEKYTAATALLEDGTKLKNL DASSNLDTTKTTLESAKTALNAAVDAVKPELDFQKTKTSAAAKVTELESL VNTALKAELQRQVNALTKDHATEATTMLENLTSLKDSLTSLQDLVSKGLA MQVDYPQKYYDADNKSAFDNALLKASSVFPAFKWTAQSIMVPAPTNGALP NPRAWTKAREKSEFKLQNFVMAPAQAAATTPTQPAAVESTSATVIVAMGE DSAEEGAQEEDSEAASPTAEASTPTADLASTVSYLKTLETELKTQSEALN GDTTTNKTAYYKADTTRTLYWDGFMPKIVLDNFDSSWAQNSENERKIREW FGDATNWEGLSDQLTKKLGAERFKNVKLTFKSARFSTDPAKVPTVAFTVA AKDGYTLTTGDNASATEISLVVRVLYNRGSESTIQLPTQGASASAVPNKT TKVNDENVLRTVNVYLNYTGPSIVLDQAVPAVGITANTSLNGTSNVTGDF NTKFKKLLVRVLNGGHAESSLFQAIINYVNKFDPKFRAAFVTNGTNGVTI TKVEKTKELRPGTLDDLEKNRNNVFLQQIKGDKEAVYFAVTALTNDKWLN TVLVRIPLTKFVKPLTEFQAQSPTAPTQEASGDQVQADPQETQMGTQAQS >MS53_0068 conserved hypothetical protein MYRYKAKLASTNEVIAQSNTIEDLEHNIVTFRRLQKYAVHTRANDKIQIY HIEQNHKIGKRASKEVLIKVV >MS53_0264 putative phase-variable hemagglutinin MALYWDGFMLKIVVDDGYVEDIEENNKENNKNTNQQKLEAWFKANQDKFT LVADQLTRKLGEEKFKNMTLSNPTISWDEVKFSNRGSNKGYLTPKVTFNL VAKDGYTLAEESAATVTLTIRVLYKDSNLTRNVLSTQGAYYTATPSDNAT TIKKVNVYLNYTGPSIVLDQAVPAVGTANNTSLNGTSNVDNDFNNKFKKL LVSGTTQTPLLQTIINYVNNLTLNFQLHLY >MS53_0117 hypothetical protein MMKNVSEFTNFKNFYEKLHSNIKAHYNKEINDLYKRLNLKKKLKIFYSLM GVFIAIAVALLITVIVLYKKEGFSFVIVFLALAMFAFGGLAYLMFFFADK YKERFNITVAKMLNKRVIYKEAFALLDEQFSYDEEYPKQYRDTLNEVTVV ELKKLIRPILFKLKADLETIGDEEKITLSPSHDAYFVNMDIKVEVQKNRN NSPMYKFLKTTLLKIDTKNLGDKGFAFAAAFENSKLIKEYNDLFKSFRLQ KVKLESDAFNKTFNAYTNDELKLRMMYTPLAMENMVKLHQNSKSVQKISN LVMISDGSAIYFVFTADMGFMEINWEKDYSNPDQLLRAIINDVALDIYNL YILISYAYIPYYLK >MS53_0266 putative phase-variable hemagglutinin MKPNDATVIKNVNVYLNYTGPAIVLDEALPTVGEKENTSINGTSNVDGDF NTKFKKLLVNVVKGGSRWIFIIPSGN >MS53_0366 conserved hypothetical protein MFQKHWFVKFLKFFRIIDIEKKPISEREYYSILIKVKFDVYFLGLLYWVL NIMSVVSVFVLSVLATIFLAGTVKYNNGENPFTSYLNENRSSNYILLTAF INTIITFVSGTLSFFVINAKYVNSKDQYQKLELEKMLFDSNIDVYKNKDQ KEKEYILYKRSIQIINYNRYRKDTLISMVKVDKKPEVKTKESKTNDSEK >MS53_0662 conserved hypothetical protein MKDFMKLKWLKKLIVPTSLVTLTTAIAISCGAPVADDKKDGEKKQGQQDN PKAPTNPSSSLVDQKAFDAYVKEHNSLIYNPAEKGSDKDNYPTNFDALKA IADRSFSLYVGMPNPQASYVGTMWLLDYQKISDTQYKMFFGTNFHVAAGI VTAQNVNENVAQNDVAAENRPIGFTIRAAVGTNPNDRNATTGRNYYETSV LSETNKFKVFWHARNFVKRSEELNQVIAPDKDLYTDFSVLEWDVDFNDIQ NNPNFFFNPNLRAEISTSTNGSNTVVQTVSDEVAAKRKANNDRFIEKLKN AVAAVDNQIALGKKTTLYNHLAGTPFNFDFSTSLNVKDKYEATNLIYKRP TTPEQLQSFASSLTQQEKDFLETKYVDTPRWVNLYGFPLIQQNEGFGIYA SIWQEAGEPNKLQEKGWDVYPKFQSLFRFDRTQLGKESAITLQDGRKIIQ ASFNNKTLYFYGYQYKVTTPVDVSGGVSGALVTDTQGLSLGIFNSKDNSF VTASDSERPELGEWRIFNIFVIPFTQMEKIGRVEAYNLIDGTDKTKFPNQ TSSYRDQLRLVYNSGSTKFKTALFPEGA >MS53_0230 putative phase-variable hemagglutinin MPKIVVPTYEPDTTDDNKAAHEEANKTKLEAWFTNSANWVGLEDQLTKRL GSDKFKNVKLTYKSITLTDFTADKSKGVTRWYPTVKFNVKANEGYTLDTN SAKEIDLVVRVLYNSAEANAANVFTHEGASSSAAPGNPTEPNNATVIKNV NVYLNYTDI >MS53_0316 conserved hypothetical protein MKKRKKFLNHLITAPLIITSTSLIAISCTGGSNQGQEITAEVTFKDGETE VSKTTFKGREEFSINLENHVPFGYDFKENQTLLYDVKQNTSVTVQVQQKL TKFSLVDRATRQELAKVEGFFTDRDEKLTAFLQVNLPTNYQLDSRFTLDG VHLFEDNTVFLSKSTTNYTTTLNFKLQDNTVVKTVTLNLDSNSLLSLSNY VPAGYELVDKSQRITFNQSNDFVVKKVEASQSTPRKSDVINQDKVVLDQS NNTRNSITINGPAYILDTLNLSRTTFPSDVVFNSSFSVNGYTFLNVVVKS YDDALGTLSFSSTVVNSSNPSVTGEFDFNLSGLQQTKRIFSVGTDFNENS LYSKKLTNATADQLSKEEILSGLKSFTGVDQEFTVNYDLLDLIRKNRVSV NTMQIQDNGTMLNLNLDLLSKRLENGEVTETKVRLIDKEVSFNTGYSLNG ELSYILNNKVSVASLTGSSVQNQYPSYYWGRIKKGIELANTLLQFDPTFV NNQQVKTTNDKVIQVKYENLVPNDLTGELTFDAYLVALDSTANDGNIQSS RRRFTVGGLNKLNTKMSLTDPVLSKFDLSIKSSGNKSIIANLVKNNSTDT NFTNKDTGSLFKALSFTFLLSEADEAEQKNNSFWDLKFNNVDLQSAYDSE TKLLKQNENELFAPYKIEVEPISFSNYSFNGTTVKFTLNVNLKVTLFAGD DKYEFTKSFRFDNQTLSTSSSSSSSSSSSR >MS53_0556 hypothetical protein MKTKKLNLLKVVAFGVLPVASGAALVSATSSVNSINARSNNFWSSGEDFE NRVGFTFKDDRWGVGSFNYTGGKNALIMMQNVLNTIV >MS53_0555 hypothetical protein MMVSRDMRIIPESLEILAVPQNSKQPASDFDKYAWKLKDQKDQWKYQTQN DWTYIDYNVGFKNSTVSSMSMWHKSYFGRNKFSSEANRWEVASWAESRKH LQEHNGLGLFFLNRMYNLNKAWQENVYKRWKAKDMLPTPKLSWRSKNRER YSKYTGVGNGDAWAAKAQQLNDFYYRSFNSVDLAGVGETLTLRLKQHTDR YKKEQGWKYVLRFKTEFSHKYYTEETARYYDKFKAGSSGQSFVALGYSTN DWNYQTKYQYKALFLQKADRTGNEKFDVNVKEMVDSKYKGFKLPKASFKL VNETLKALAAKDPYVPEMNKNNFNWDFTSQRGQKVYQTQALSARRAQSSN FNARFEMM >MS53_0471 conserved hypothetical protein MIKAKKIKLLINFGAISILGVAGAVTAKVIIDNSSDKARDLNVIIVSRGD KSVLNLKNVETDDINSSNKDNNLKEIKEETITPVVNDKEENQVESPVEPE PDPEESNKYFSDVTKPIENPQPEPPVESKPPVKPKPEPDPEPIPEPEPKK PTIEDMLPQSSEGIVNINNLPDLDFSTLKPVETPKGQLSETEKRTIKTAI NNLVRISQNIPTKFTQEQIDEINKSINDIRKLNAYTKNEKDNDWSSLLNG LIVNDGRTTEEKANAIGWPYKDNRHNYSLSFKLMWENYQRDLDAMLAKGM VPSLQWGSFGNVWGFADHSDNVVRNKLIADNNRRYFPYNTEYKRTSGVIR NLDYEGFSKTDVTNSYRNYGAESNKGITVLEYTPTSDYAKSQVGTKRVMA VLDATNREGYNSFLKFLQDATKAGKKIDGIVIRNMGLIDKTQDFSQILAQ MPDSIQKLTLFFEGKDTSSLIGLKDKKIQEIDLYNSSNTIADDWAINPYA LKGVKNITFDYNYDIGFPGIPGNNRDMPGSIVFNTLKFDKGMSLNQINEG LKIALNDRFGERIFQGQFGDGSWPTYLDFSNIPEIRSLQDMNFYDRVFKK LTLFNKTNVFTVDAKTLHLQQWSALLIKGPDRPKLMFVSPQKVDTLYIKG NAVDLGNNWGPELYGLIESGKAVFNTVYVDNEVMANTLNNSQAFTTFGKR AIVKPSNFDTNGGNSEIISFE >MS53_0171 hypothetical protein MNKAAVKKSKLLWIKNRQFIIGFWFFTILLSVANLLWSSRVIPLYYWLDF EIDRTLRIFLALLFLANIFAVGFIFCIYSKITINTLYSVMFFACFISSLS FFPQVLINSETNKTQLLFIYFKFDTALFFVLHGAVWLLMLVFLKPKYIIN LRVKIKNKKITKN >MS53_0248 putative phase-variable hemagglutinin MADLASTASYLKSLSDSLKAETDKLNGDTTENKTAYYKADTTRTLYWDGF MPKIVIDNYVADGYDVANNAENNRAQHEAANLEKLRTWFATPANWEKLSE QLTKKLGANKFKNVTLTNPQVSYEEVTINTYTWKNPKVTFNIQAKPGYQL TEPTTEPTTDSKQISLTIRVLYENQVSTQNLLTIQGASPSAAPNGANTAD HPQTIKDINVYLNYINQFKLTN >MS53_0245 putative phase-variable hemagglutinin MLIYWDGFMPKIVVQGYEADGEEKGKATHKEANQKKLEDWFAANQDKLSL VADQLTRKLGKDKFKNMVLSTPTITWDEVEFSNKGSNKVYLTPKVTFNLA AKDGYALAEGSTTTVTLTIRVLYKDSNLTRNVLSTQGAYYTAAPKNAIVD DANVKAKVNVYMNYTGPNIELDADLPRVGEQENTSINGTSNVEGTFNDKF KKLLVNVVGESITQTSLLQAIINYVNKFDPKFPAAFVTEKNGVTVASVQN NTQLRIGSLNDFLYNNKGFLQQVNTDTKAVYFAVMGVTSNGWVNTFLIRI PLTKFVRPISVLEEQTTEEETQESQEGQENQEQGSTTQTNTESSGTGQSS DLTEVSA >MS53_0099 conserved hypothetical protein MKINFKSTILQNGETKEFDFTASVDIDRYEDMDTFSFTEPTQNVANRIEI SHKKINIFAGATTLFIEKDKNLASPFILNTPDGKVMEVNFYTRLLNLEID PLNKYKFEYILYRLNDYQEDVIGNFKIELTIS >MS53_0359 hypothetical protein MNKINIKKWNSEIKSFFNINLGATTIRKNKIINLFLNKNLNRIHGLKIQI INLIGNKIHSADEIYNIILSCVIDSVNNYIKQNISYKFEAFFWTDLKFKT LTKLNKFANSQQKFEYKISNSQVNLKNLKSKITLANSEVFLDSQISQKLE KIRPTLTENETRFLTLYKQNKAHLYYSGFMQNRLISQLKAKLESS >MS53_0594 conserved hypothetical protein MFLDKNKILNYSDENKLWNDYNKVFFHYVMWFIAGLFSLFLVEAIQLLLL VVYKNDILLSFYKLAQQQNLSNQESFAIQSFNQQLGIQIFTALLYLGIAV YFAYTTFASRKLKSYYHLSSFVINTLAILIIVKVIMLVVFTTNSSVGPIT GTEVPALIAIYVVSVVASVLVGLVFLRPVSLIKKSFVFARRRNEFMKMQE MFKNSQSNPNGFDLNAFFNHVNNQNKDPYMKSQDEQAYQDNPYTGQNDKA QNVKSEKDLKIEKLLSLPKEQLHEIAKILNIFGYEKLDKKELAEKIYNYT KDKK >MS53_0219 putative phase-variable hemagglutinin MALYWDGFMPKIVTTALPTTVAPMNREYNESPTGGHEFWKGRNKQVLDAW FAANQDKLSLIADQLTKKLGKDKFKNMVLSTLTITWDEVRFSKGNVTKLY LTPKVTFNLAAKEGYALAQDSATSVTLTIRVLYKDSNPEVNVFQTQGSSP AAAPSGSSVDDDNVKAKVNVYMNYTGPAIVLDQDLPTVGSANNTSLNGTS NVTGEFNTAFRGNPTKGLLFTNRYPNPLLQFVINYVNKFDPKYRLHL >MS53_0188 hypothetical protein MAKVKHVYKYLIAAVSFLVAGGVSLGAVKLYSDNSSQTKGALNPAENELV NVFLAKDSSPELKFLLQDKKTSVASFGKYQDGQDNLDRVTYSGRSYEYED FFNVFYLQNGFLPVLEISYGSFKFYNEYLEAVPPHEFLKFAQWFVKNVSW GPDMLTLKSFSIVKGVQRDGNSITLGQHLNANKELQTIKFYPDAFFGSLS LYSFLAGEGNLQDSLLYRLNSVSITEEELNFFLKNAKKLNILANEPRNTQ QSNIKFRNLLAAQRLQNRKLYVYSDSEAGVKQVVFLKEYDPESASSQSEA QARLRDLLKDPSFVFDSSKLKEYYVSGLGMANADLLSKTYPELASLDLTP SEEKETNLKNLPVTRNGRMALYLRFVDAAKGDGAIEAAKKAEEALEAKVL EDLQTNANDTDAKAKVAAELDAIKKALYTPDETLLVTDYDYSAQALSNLD ELEKYEFSQPTVDFLDYYDLKSLIGKTFNLYQSPQPQQDQSESQEQSETQ EQGSTENTENTAPAVAPGFPGATQPAAPQTSLMVPEAPVKSDATDAMAAT VVDLNDKKNLTLFSPNGKEVEFAKNYASLVDERNFKDPETGKVDFPAFDT NLLSQARVSDISVENGVLTVDLLTHNAKYRYSVDAKSMSDRDWDFVQELF SKAGYVKYLDPYLVNLDSDIVTPEGKRERTFTLYYSAYQNLLDNISRKMP YLLSDRTGPHVVKKVNDQGVVEYKLEDGPYKGFSSDDNIGLWAVLKLSDP KFKGMSSDFLRFVGAHEYGHHITLTGAQDLGDKQYDPVLASAQSPRGATN IQNFISKENLDLYLRARTHLEAKTTNLYAQGEKEINSLPESNTGNFVNYG FQKKDGSYAYETQSDVWGAPKADPSIVRALTNPKRRFLQNFEGLQKALQE RKKDYNLSDNVDLFDLWLTNAFDEQSGTLNPTIEGTAQYFQVDTSSPTGY TFKDASNDQIKDYLKDGLGQKIEYSNGGFVLFKFVPYDPQNGLFKLTSNK VRRENGELYVNIPEGSVLTTAQFSELKRIEREFNENVNNFIVKRFSSNGW NTGTAITDTNVQITNAVPYSLRYTSQDELVNGEYSKATEFYKNFVNKRSW TNGLFGNDEFTFRTAEADDYNITYWPLYFAKTSFYGPENYRNALIFDEGA LTKTREYAYNFPVRFPGLSIAEVNKTLTEFLTLFPRTLTPQERSAKQNQI RTEAERRKVFDVFMQTSYAWRGHLPEYNVVDTLGGNKLFLNSTHQYVPNF AQRRVVYNTNTKETTYKDPYKSSSFLNNTPISISNVVNGLVWFKNLNGRI YSDYAPWMRPIGAVDNDGQQFATAYFFADENGTEIEAESPDETTKVDLSK RNAQTLVVNTDFGVSDVQNGVFGAIKLSPGKDKRVLNDLEEMFDFMTVDY EKAKATYDAATKQQVLNWDIDYVEARLDLETFRSRYLSFLQNYKGRLFTN KERQDLIDLYSKPLSETKQEVANQAMQRFLRSGYVPFAKDYQLKNFLAKR DNLWVLDKNVGVDNLKSSFVDLTVTDADDNRNVDRYLKFVKEYFDKHQIM YDNLTLFDLHLLTGITWFLPDAKTSRGFVNKEAGQLTVRNGVSSDVDLYF STKISSETGSIFSDYVYSYAEQINRDYLQTTYTPSYDQYGNRPDYISGIT EVTTGLEYIVDATASNKYQNFQVDSEVTNNMLISNVIPYYVEQNNRNRAA KNGLPNYESSKRDNYFYWLPKYTNNFFGKIRSFNNGWYKDRFYRTKLNWE LYDEHGLDKQDNSIRIKDLLGQTVTSRAKAYWQYLIRSQGIGDRTLSGFW RDSDKDAVAFYGYFDLEKSQDLKYLAFENTATKEVSYLPVHVSHTNNLFY YTKQAPENGYTDVNRHYIKDEPYLDKKTNTQRVGFASWVSDYALVSQYRN RLVSPGNTYNVYFANSNKEKLEDVDLGSLVSMAENGKLFNQSPLTVQKVE NTDGTHSAVLNVKDQFNSN >MS53_0335 hypothetical protein MIMKKPFKKLFILSLSLPAALAASSCSSFSFHPYKNTYNEAFSKVEAKHN KLENSSNKYLKAAFDNYYENAKKINQDSIDNPDHFNDNIYIQLGASINAI LKSVEIIEKDVLRGRQPNSPEFLEIYELIWGKISEHQSQLETLIINSLNS IASNITSTNLSQETLDKLKKVSDSFNNYISYYYQIIKTHKSSFYETLKFS QSFDDKKSLEIINDINSKFLLYTNYVNEIMTNPNYNYIENENDFKITILG D >MS53_0451 hypothetical protein MKMKTKKEQKLVTGSLIERTALYITIQSHNQLYRVYKNNLGKDVTLQNCY NSFEKDQKVEILVEIGVKKTKYILANLNKANCKITISDETENGFLNLKKF TDLEIENYT >MS53_0668 hypothetical protein MKYNFKESSFALFKIFKKYIFIFVLFSCFIFTFDFLAVRFYAHLIDNLSE NKEKISLENKDICFYFLVLFLSIILTFVYKKFNCVFWK >MS53_0261 putative phase-variable hemagglutinin MADLASTVSYLKSLNDTLKAATDALNGDNPTEKTAYYKPVNGRTLYWDGF MPKIVLTDFDKTWEQNSENERKIRKWFDNAANWVGLSDQLTKKLGAERFK NVKLTYKEVTFSTNAVKTPTVTFTVEAQDGYTLDNSANEISLVVRVLYNR GSESTIQLPT >MS53_0543 conserved hypothetical protein MMNSIYILIPFIVISMTIFLFIVIKFIYLTKKMERGVILFKIDYLNKRVL RLNKKSKFFNTVFDSKKLNFTTSNYLSLNTFYDLINKEDLTKIKDYLDFQ VNQKEKIDFRISKSASKHLTFKEKIIWKIKNTKNNSISFVLTINPSQDAI YYCTLKWEFNNQNKTKKIIEDNSESYVRAIKTNKNIAVLAFSLKTYYYIN SINLFDIYKIVFFLNIPKKSLRFFQKDGLLFFVFPDVKSSKYRKLLSYAK NIQSLSLANKYFINGTIFKNKNYKTLDDKALIIKKAQFCIFNLFNLNICK KTNNLLKLNSKTTEEIEVKNKESLNVFYNLDLHAEDTNSFLDFHRNLEEY IHENAVAKNFQIKKSYLYKYGSEPKQEFSPKDVGYADVEMTNIRESDQRF FRNIPYLNFVFEPIWFDFIRKKQIELLKEENLKKDYVKKTMVKVSQESYL NNPNNYIESSPSVVIYSYKNNFERQKLSKIISQNKQNKVTTFLYIKEIDR STLHTVSVCDFSAVIIAKEISEKIHHNETLLNCISLISLCEKKNIGIIYE NAPEKLSKALTNMAKMNFLIDKI >MS53_0672 hypothetical protein MLTLKGLMELTKIKQIFFEVISTIPGIVNINNINGGDKSARLLDRINVKK ENEYLSFYVDIDILLGVNVSSLVQEVSQSLHFKFKSSKYKIKEISLFVSG VIYE >MS53_0087 putative P37-like ABC transporter substrate-binding lipoprotein MEVFIFNFKKLKLLLLIILFSSFVASSCGFASQNEQKLQWDATLTLYGPN SGNLFSENLKSAWIKKVQDKFNELKNSNPETKNYPDVVFDLKFLDDKNLI FQNLNNNLENYDFGILNATTILKNKNSDLISHPLLQTKTLKFLWSLDDSK TYVDGSENDPLITAASEANKIQFENELYGPYSSWNDENKKILLKWDGSKY NVFYKDFHDSNNFSSVFRGSILISGTKEIRDEIIKAWNDKNWEKFLSFGI VIRNFESLSRYNAQVEILAKQFNKNVSEIKTELQNPNNKNVLIGRASNSL GVLSNQGKVFNIAFDYEGVFNWTPPYYGSGNLIYNFKPSDNNSSVRYLTF TNPIIYDQVFARRGLSEIQKELFAKALASLSFEDNTYGNYTGYNQFSLVG NNEK >MS53_0250 putative phase-variable hemagglutinin MPKIVVDGYVADGAGANKAQHETENTRLLQQWFDTPANWEKLSEHLTKKL GANKFKNVTLTNPQVSYEEITVNSNTWKKPKVTFNIQAKPGYQLTEPTTD SKQISLTIKVLYENQAYTQNLLTIQGASPVAAPNTASADNPASVIKNVNV YLNYINQFKLTN >MS53_0056 conserved hypothetical protein MIMVNFSFPLSKVEDLSNYKPGFFSWFGTKAYWDSNLPAFIKNGNFFFIF AIVVLFLLFVGMWVLKRQIIAKYKLSLQNNSNFYKYFHMTLGITILLWMI GRSLIIYFVMGYPRYWETIPVHFCRLMGIMLGVLLITNKLKYIKYVAPLA VLGTLMALLSPDLTMEVYFDKNVSQSDLDALSAQKIFLSGRDQYINFKVE EVFKLRWGIFNFIFWDYFFFHTFLLAAFVTINFLNPGKLGLKEISKTLLV CFMFVGAMASINHLLDNSPAVSINWKSNYWYLGTNEINNLSTLVPPFTEF PFSIFTFVLVGVVYLLFVSFMLALQDKVYINVFAKGKQVKFKIIESENYL YWKSSFKLAFSSLLKTMKKLFRKA >MS53_0259 putative phase-variable hemagglutinin MKFWDGFIPKIVVEGYQPAGDGSNKEANKTTNQKKLEAWFGDAANWAGLE DQLTKRLGSDKFKNVKLTYKSITLTDFTVAGATRWNPTVKFSVKAKDDYA LDSTSAREIDIVVRVLYKSAEANAANVFTHEGTSSSATPGNTRTVSDTNV LRNVNVYLNYTGPAILLDADLPAVGGQENTSINGTSNVDGAFNNAFRGNP SKGLLFTDRYPNPLLKSVINYVNKFDPKYRAEFVTDSKNGVTITKVQNTK ELRPGTLDDLKGNNVFLQQIQGDTEAVYFAVTAVASNKWLNTFLIRIPLT KFVRHLTEFQAQSEAAPTQEGQTTQGQEKSAGSGALGSTTGTQTPSGGSS QASGS >MS53_0429 hypothetical protein MWNSMQSLNSALQQEYSADVLNDAIAENSFSSNISSFFSVSFPDNLVPNS FSALKENQSVAETAQVNATLKSIKDSDLKLYNDTFKGVFDNLKALKTYEF SSTNLLGDSKVRATFYKAGSDAKFEVDATKVNATFNLTSLSETSLVKEVN KTGNYLVKVSMNAFSIPLSILKAFQARNLDLGPVQSLGSGYRFVGLIPFF VRNFDFTSSQNQYTLKLDLDYKFGSQEKFLTENQSNLTEANTLILLSNNF LQQNVDTSNVNLDLYFVVTDSSQISKFDSFLNNQEKTNLNVSFSF >MS53_0158 conserved hypothetical protein MKIKLKKKLLTSSLLASSTALSIVAISADTDSNTNTNNNGTGGGTTPKTP ATPPKNADDFDSFKGELDKKVKENVEKLVDDTVTALNNKAKELIEATKSE PNIARDLIAKALYYQKVATYLQTNKAKLVSDKTFDPTYLNALANDKKYSL GNITYEGKEFSNVIIGSNPNDYASALAKDSNSKKEVTEKDKVNDISKDDL NSKINDYFKNITDNENENAGDNIFVNKDDLPKLNTDTELTFDKTFDLTTP KNYSSWDDYIKEKLQKRFTIYDISQNQDQNQEQKKQQDNTQQNQNPIPGL PKENEDDLNKNIASQNVPRIAPFINYKYSGFTDYNDILARTGNSAQLFSF DNPINPRFEYRVTEISNFNLDPGYSEFIKQNPTFFDDRGNFPIKVKVEIR DLNDPTKTATYAIGYVKNYGNSTLAREIANQIVQDTYSKFYTALGMKPDQ LNFTNVGNAEIAAAAFDLMGVTTGIINEPKYNASYIDLLVRLGSGVKLEE NEDLKTAAKRYENTSFGKAVQTLFLSAIKTSNLNNSAYWTFFSTRLESVF AQLSFNINNSNSGSTNRDKIREFFAKNPNYSVETFDKAMQSLNSRIQYFK GLAGNPTFDESAQYNTMMEQLTIIMEQIRNMTTILTDVLQSQAPSDQKKF QAAYEKLNILPIESGQNNKIVLASIGSILMLISIGLFILSIFLQNFKRRK WLSNKTNKIALTWSITSVTFIIAIALIVFAILGGI >MS53_0443 conserved hypothetical protein MFVLSFSILIGILLYPRQSGLIQFFEYIKDFKYDQWSFWFSLSISINGFI AGILLIFINQYSKSRLINCNYYTCWNFLINRW >MS53_0470 conserved hypothetical protein MNNSKVLRFNWEKENILRVIALSTLFIFVVIFGFLFEFAMKHLSVNLLSY EYLFNTSYTLHKGSNFYVFYTVILFGLLIIISTMKSYFLVNKNNLKFSKY ITWYVLYNFYALALLVLFAFSLNVNSNTQANTLLRNSFVIIPLLIIDLSY DFFSLSMQKKYFTLDLKKIILEISYLLIKIVLIVIGFYVLQVFLADKQIT AIFINNSFINHLQRIFVVTPIYKNLIIFALIFVFALMIAHKFFANKNKIF NSVIRNKILKHLVQNFLMLFLASIIFAFYALFKTKTKELIFKIENNNELI IFVLVISLIILSSLSFIFLTIFLQKWFNNFDQKKYFILNLLINSFLLLIA NLLLNFQNRLIINITCLTLVFMNYLTLLLKNKYKLNSFENLLLSFYLIAG SAILIFSNLLYLTTNENNYYLLVWTHIFDIATVFVLASLVISLLMVISPI IYAILTKIVNNIINKENIKKGKEHVQKASKKSN >MS53_0649 hypothetical protein MKKLKFKYKLILLLLSATATLSATVGVSVLAFSKVQNTKEVNRIYYQEQN INTIGGSVVTLDNFVFNASARVKNYYANSFSNHRIYNSANSGYDSTPNYW SKLLTFSKAPTLAELQSKDFTLMTPDGIFLNYYLGAFQISFDSFSDELNG TLYLQVTLTSKTNPANVITKVFEASGFKKVSEDSGDLNLRNLLSFNSVNL NFTYLDSFKNLDDFKAQYTSGAATEKLSMIQSAFNFETSTVASVDFLNSS LVFDDNNDLKFNLRLTANVPMAIPTNLDQKVPLDNIYLDITTQSYSLLKD YFAAKAVGDKLSFATDGLDKYTIEDIKKSFDLLGANYALLNVNNLPVEYN LKFIEIPFLNPERNEYEFIYNLYLKSAPSQLVYTAKLSLPKTALKAEEEK ASEPQQN >MS53_0253 putative phase-variable hemagglutinin MREWFATASNWAGLSDQLTKKLGAERFKNVKLTYKEVTFSTNAVKTPTVK FTVKAKEGYTLVDSGENASATEISLVVRVLYNRDDESTIQLPTQGASASA VPNNTTMVSDPNVLRTVNVYLNYTGPSIILDEALPTVGSQDNTSLNGTSN VTGDFNTKFKNLLVNVVRGGHAESSLFQAVINYVNKFDPKFRAQFVTNSI DGVTITKVQNTKELRPGTLDDLVKNDRNNVFLQQIQGDTEAVYIPVTALT NDKWLNTVLVRIPLTKFVRPITPFTASAVMIPTTEDSQEESGENSSQADN TEQNAENQEDGQSGGEATETQEAQGDSASQSSPQT >MS53_0304 hypothetical protein MNMIFIKATLYKVASEKIKGFIDYLYVFVKKSQMQELNLSFEYAITKKDQ EVVSVLLVQRWTNKQAYEAFVTKEEFKKEFFTLKSFAKETSLVFEVTTAK >MS53_0207 putative phase-variable hemagglutinin MTIRNLYKEANPDTNVFATQGASSSATPNNASQANDATTIEKVNVYLNYT GPNIELDADLPTVGGQENTSINGTSNVDGAFNTAFRGNPTKGLLFTNRYA NPLLKSVINYVNKFDPKYRATFVTEKNGVALTSVQSGTQLRIGSLNDFLY NNKGFLQQVNTDTKAVYFAVNGVTSQGWLNTFLIRIPLTKFVKPLSVLQA ATDSSQNAEQTGETQGSQPEAQSQ >MS53_0646 hypothetical protein MNMTKTLNKKEFFKLQKYKRIEKDFNTKSSYSIWHLLFYLVVFFLNSILL GFSLLFLLRSDFLPAIFFEIYIYSINSWLGNLVFPLCLLVYLLLMMVLLN KLFENKALSWFSSRDVKIPWKVVSKKIVKFLFYWFFILALCDYLYFHYIV YENSSLFFNPTLVRIQELFANGWWKYFNNSQIPLGSFLHVGVIFDSLGNA LVVASLSWILTLFLLVFLGATSFAELIVVDLSKNNASIFKRENNLQEYKD YLRYSSYHYSYTTSVEKYLNFLMKAAIYFKLDYIHSTVEDLEKEVFEQLK KEKIQEIEAVKLFEFSKADEARANSLYLENQTLKDQIEKLTVENRNLRNQ EKQLDFFDENHSAWQNNETPFATNLRLARPNQGFTQEVKVTQAVPIPKPQ VKTQVVDTGPKPNDGIFANSKPAPVVKKAKIEEFDLDEFLKQEATQSIKL EPEFEEVRPLFAPKPVKETKKTVEELNREALEKQEFYNWLEEKNSSKVGL FKPRKLGDTSLGMVHESDGILRDDINPKNFQPKNQRMQTKQKGHYTYSDE KLQKITNEIDVSDFLVDDN >MS53_0241 putative phase-variable hemagglutinin MQFTSGSVTAAKAVKEDAEYSKVTDTIKTTLEEKYTAAAGFLTEDSKLAN LNADGTLATTQSDLESAKTALDAAVAAVKPELDFQKTKTSAAAKVTELES LVNSALKAELQRQVNELTKEQAAQATTMLANLTSLKESLESLQTLVSNGL KMQVDYPRNYYDADNKSAFDDALLKASSVFPAFQWTAQSIMVPAPEEGAL PNPRAWTKAREKSEFKLQNFVIAPAQAAPATQSDSTAAESATVRVANGEA TPAEGAASREAPTPAADLASTVSYLKSLSDSLKAETDKLNGDTTENKTAY YKADTTRTLYWDGFMPKIILESFTASQTNVEDNKSKLQTWFDTKANWSNL EDQLVKKLGSEKFKNVKLTNPQVDWDIVNSNQYRPKVTFDVTQKEGYELQ SGSEFSQSLTMVIRVLYTTQSPNANVLQMQGASSSAAPAGSTPSNNAAVI RNVNVYMNYTGPAIMLNADLPTVGGQENTSINGTSNVDGDFNTKFKNLLV NVVGGSFTQTSLLQAIINYVNKFDPKFRAAFVTEKNGVALTSVQSGTQLR IGSLNDFLYNNKGFLQQVNGDSSAVYFAVNGVTSQGWLNTFLIRIPLTKF VKPLSVFTAPVVTPPAEEATEGSQTQASIPQTIPNSSQ >MS53_0062 putative acyl carrier protein MNVQETVFAHLRKLTKKEFHLDSLLSDLKLDSLDIAELIIEAEKKFKIEI SDEMLQNLKKVSDIVNLITDLVEAE >MS53_0243 putative phase-variable hemagglutinin MVVNGYVADTTGDNEAAHEEANKTNQKKLEAWFTNSANWVGLEDQLTKKL GADKFKNVTLTNPVITYEKVTVNTYTWKNPKVTFTVEAKPDYQLTEPTTN PKQISLTIRVLYENQTSTQNLLTIQGASPSAAPSNSSVDDANVKAKVNVY LNYTGPAIVLDQAVPAVGTANNTSLNRTSNITGDFNTKFKELLINNLMPR EFLSTVINYVNKFDPKFRAQLVQI >MS53_0467 conserved hypothetical protein MIQLNLLSAKNIQTTVKATDFKVNFNLNDKWNKIENNALLSFQNVLCSLT YNKKEYFIFFDSLLIQSNKGQINLYYNQEYFVYEQNDKNKNELKKLNQEY SKLKKNILLKTFQINDNNNASNIANLLILKQKAYRLKAQIYFSLFACEEP WK >MS53_0256 putative phase-variable hemagglutinin MRDVNVYMNYTGPAIMLNADLPTVGGQENTSINGTSNVDGDFNTKFKKLL VRDNAQTSLLQAIINYVNKFDPKFPASFVLNTNGVALTSVQSGTQLRIGS LNDFLWNKKGFLQQVNGDSSAVYFAVTALTNDRWLNTVLIRIPLTKFVRP ISVLEEQSAQDQTPEASQQAGGDQSTSSSPQGTAQTQSNQGS >MS53_0131 conserved hypothetical protein MNKLLSFSLLSLVPIVTSSCGTSSVKNSVDSNEQASTSLSRESIASFDGL LNYVFNNNQVAVENFKNSQDQILPAKFNEVKQALVWAPPFYVNVLEQNSE LKKQTSDSINILKDTFKNDWYWMVKNISKFIYQFNPYGQLYDDEAAQKQD FDLIEHLYGRLDKKINWNEIFYILSYKIQVDPDANETFKDLTAHFYFLDD GFVKFYTYENQGKQNLFFVPDYFKIALSDDDIALVDLTANQENSNGNTTT KNYKAISLQKEADQEKYKNIALDFENKIWEKWTQKIDSLIEEAKEFGSKT EEEVRKENTYEKFFQYFSNVSYVGMQFKAINELNASNPKTKLFKYTLRWI DEN >MS53_0554 hypothetical protein MHLDECQKYLKDLFVAKAKGANYYAVEALKEKAKDLNWKLGKSWEKWRQV ESWIKSDEFTSSTDTSGKSKATDALAKAKKFLESGENGLTLENFETKLNS VSSTLDLSSLKLKPEPSQKTVSQKSYDQLVSEVSKLSYLSSLEKSTYLQN >MS53_0206 putative phase-variable hemagglutinin MPKIVVPGYEADGAGDNKAQHETENTRLLQQWFATESNWEKLSEQLTKKL GANKFKNVVLTAPTVSYEDGGSNTRIPKVTFTLQGKDGYTLQTDNGATSS LTLSIRVLYTSASSTQNALRYQGASSSAAPSGSTPSNNAAVIRNVNVYMN YIGPNIELNAELPTVGSQDNTSINGTSNVDGDFNTKFKNLLVNVVGGSFT QTSLLQAIINYVNKFDPKYRAAFVTEKNGVALTSVQSGTQLRIGSLNDFL YNNKGFLQQVNGDSSAVYFAVTAVTNDKWLNTVLVRIPLTKFVRPISVLE EQSAQDQTPEASQQAGGDQSTSSSPQGTAQTQSNQGS >MS53_0212 putative phase-variable hemagglutinin MDDLVVKNKNNVFLQQIQGDTEAVYLPVTAIANNRWLNTVLVRIPLTKFV RPLTEFQAQREAAPTEEASGDQAQADPQATQMGTQARS >MS53_0267 putative phase-variable hemagglutinin MNWDGFMPKIVLDNFDSGWTQNTANQDKIKAWFREASNWAGLSDQLIKKL GADKFKNVVLSNPQIIFEYVRLLTSESVKFPKVTFRVAAKDGYQLASGEG TSTTLELKIRVLYSSSNPKRSFTSISRSFIFSSAR >MS53_0205 putative phase-variable hemagglutinin MASTVSYLKTLETELKTQLEALNGDTTANKTAYYKPVEGRTLYWDGFMPK IVVPTYEPDTTGDSKATHQTTNQQKLQQWFATESNWEKLSEQLTKKLGSS KFKNVVLTSPMVSYEDTSSNTRVPKVTFTLQGKEGYELQTTDGASATLSL SIRVLYTSESSTQNVLRYQGASSSAAPSGSTPSNNAAVIRDVNVYMNYTG PALILNAALPTVGNAANTSLNETSNVTDEDFNAAFRGLLFTDRYVNPLMQ SVINYVNKFDPKYKAAFVTEKNGVALTSVQSGTQLRIGSLNDFLYNNKGF LQQVNTDTKAVYFAVNGVTSQGWLNTFLIRIPLTKFVKPLSVLQAATDSS QNAEQTGETQGSQPEAQSQ >MS53_0224 putative phase-variable hemagglutinin MLYWDGFMPRIVIERFDTTWTENTRNRNDLVAWFQNTANWSQVSEQLTKK LGVEKLRNVNLVYKNITWVNSPAGAQHKIPTVTFTVEARDGYTLADDSTR ELSLVVRNLYNSSAVDATTLFPYQGASSSAVPSGSSVDDANVKANVNVYL NYTGSSIVLYEALPTVGGKENTSLNGTSNITDDFNNKFNKLLIRYKAETS LLQAIINYVNKFDPKFRAQFVTKTNGVALTSVQNGTQLKIGSLNDFLWNN KGFLQQVNGDSSAAYFAVNGVTSQGWLNTFLIRIPLNKFVKAIL >MS53_0589 hypothetical protein MMASVQIIKKNKTQYVRIVESYWDKEVKKPKIREVKFLGKLEDFTKDNPN FIEELKESVSSKKNKKQKDRNEQILQIMNSLKLDKFKGTQIKGYGNLVYE EIMNYLELPSFLTDLQKKNSRSKYDLASITKYWF >MS53_0369 hypothetical protein MCFQKIFWRKRRKIFRKNIPNIAVRLILNYAVCVIQKLQNEKINVKFTNE NKLLISRKILEKINNIAYNLEKNKYNQVTSSIIRKLKMNLYWALKVDISV LFQLLFLR >MS53_0235 putative phase-variable hemagglutinin MPKIVVQGYQADGYVADGQGNNRAAHEDANKTKLQNWFNAPANWEKLSEQ LTKKLGADKFKNVTLSSPTVTYETISTGRDVRIPKVTFTVTAKNGYNLTA PTGNTKQISLSIRVLYTSASSTENALRYQGVSFSATPKDASVENPATAIK NVNVYLNYTGPSIVLDQAVPAVGTANNTSLNGTSNVDGDFNTKFKKLLVR VLNGGHAESSLFQAVINYVNKFDPKFRAQFVTNSINGVTITKVESGTQLR PGTLDDLVKNDRNNVFLQQMKNDTEAVYLPVTALTSDKWLNTVLVRIPLT KFVKPLTEFQAQSATAPTQEGQTTQGQENSAGSGALGSTTGTQTPSGGSS QASGS >MS53_0566 hypothetical protein MKMATKVTAFCNTCTLKWEYFFGETQELSMINLALNYIEQNQKNLFVKEN FFEFINKSFSGKKDFESMPQETKNKSMELFYNQFVGMFSDEERTMLESNI LLKHNLEIYPIYLSSLPEDERKVMNIPLLSLWFLNQEEYKRRYNPEIIYI QFTKEQDYLVCPKCQSMSAAVIAQDQV >MS53_0232 putative phase-variable hemagglutinin MTAAAGFLTEDLKLANLDVDGTLATTQASLESAKTALDAAVAAVKPDLDF QKTKTSAAAKVTELDALVNTAFKAELQRQVNELTKDHAAQATTMLENLTS LKDSLTSLQDLVSKGLAMQVDYPQKYYDADNKEAFDAALLEASSVFPAFK WTAQSIIVETPEGQLPNPRAWTAPRAKTEFVLQNFVMASAPAQAAPATQS DSDAAPAASATVRLATGTEEAAEDSESSETQTPAPTPAADLASTVSYLKS LNDTLKAATDALNGDNPTTKTAYYKADAGRTLYWDGFMPKITLESFTASQ TNVEDNKSKLQTWFNTKANWSNLEDQLVKKLGSEKFKNVKLTNPQVDWDI VNSNQYRPKVTFDVTQKEGYELQSGSEFSQSLTMVIRVLYTTQSPNANVL QMQGASSSAAPNNTRNANDETTKRTVNVYLNYTGPSIVLDEAHPTVGATP NTSINGTSNVTGDFNTKFKNLLVNVVGGEFHSNSIITNNN >MS53_0252 putative phase-variable hemagglutinin MASTASYLKSLSDSLKAETDKLNGDTTENKTAYYKADTTRTLYWDGFMPK IVVEGYVADTTGSSKDTNETANKTKLEAWFTNSANWAGLEDQLTKKLGSD KFKNVTLTNPVVTYEEITVNSNTWKNPKVTFNIQAKPGYQLTEPATNPKQ ISLTIRVLYSSQESNQNLLTIKGASSSAAPRRATVNDPNVKLKVNVYLNY TGPSIVLDADLPQVGTATNTSLNGTSNVEGTFNTAFRGKPSSGLLFTNRY ANPLLKSVINYVNKFKPKYRATFVTDSRDGVTISNVTNNVQLRPGTLDDL VKNKNKVFLQQIQGDTEAVYFAVTAIASNNWLNTFLIRIPLTKFVKSLTA FTTIPASAPTQTDSGTGAQTQPETQS >MS53_0069 conserved hypothetical protein MRVKFNLLRFIMNKVKKKKLIILFGFSSAILTSAAGISFGVTQLSQAYNS NQQIIAINRSRSFNLITAKAIKNSTEFNTDLNLEELKEEDKVPIQEIEEV PKPIEEVKKEEPPKVVAPKVELPQSENPPLLSSAGSIVDLNSIKPTVSEK SDWNKPTGQRLSAALQQQAREAIGKAQKAFNDVFSKLKVNTDGTAEFTKA QKEELADSLGVPADKKEWFFKMFLKNFEEGNQITDMYGMLRRDSSTAKTN REMFLHAINNVDFDFYFSINNIPYIKWEYGNDITIGGKPPSDAENVVVQH QINLNKKRFLSSDSKWRRYSPQMIADNDYFGWTQTDITSEVTSRVTLPST DGIKISKYVANSDNAVATDKTTPRYALTLDASNTRGYSDVIRNLQTLNAA GYKIEVFNVKRIGHQKNQDFSAVFRAMPDTIKLLNLFFDDTNTDSLVGLK GKRIESLGLWTTKNQLDENWGIDPFLLKDVEEIEFDYQNSQSGDYPRGAE VAGSIIFSRLRFDKSDTLPEIQKGLNVALIEKADQRAFQGYFGAGSWPSE LDFTNHPNIKTLQGLKFGPKNDLVFKKLYLYNNSFNFNLTADQLSKSGFH HLLFRTEPSKHAEIHFSNETRVNQYQLYISGDASQMTGKWIPEFQGLLYA GQKTFIKTIYVDNQEMVNRLNDSGVPSLYGFSVVVKPAGYTGNESSADLD FSS >MS53_0547 conserved hypothetical protein MKKLKKLFLFSLAPITASVAAFSLSATVASNTSESELSSLKFLSNSDKDV YRKLIDQAQSDNDKKSILNEAKSVNTELLALSQITSEASLLTANVSNLIK TISESKVSSKYADLLSALYLINNANSAYNSIKGNKTTYNASNIARFTVEQ TSFLSNLLELSNFELFETLQSDNASLNDSVAFLNTFKNKILLEHKFYANM LLGIATGQKAVFDLSIAVLKDQFPNLKENLEKTTYFIDSKKQLNSNADVE NRLKVYDSLNVEDNGILNSINFNTSMAILNNKTLFDQAVRSSNSQNRYFL IITAVLLVSLVGFAIFINAKKRKMMQKREQETLQQLKADAQNLNKETSEE TFLDETEVLPEEKAEKSLKTKSEEKSDKTTEKKKNKARKS >MS53_0204 putative phase-variable hemagglutinin MSDQLTKKLGAERFKNVKLTFKEASFSGDDIKTPTVKFTVAAKEGYTLTT GDNASATEISLVVRVLYNRGSENVIQLPTQGASASAVPSNSSVNDAKVKA KVNVYLNYTGPSIVLDETHPTVGATPNTSLNGTSNVTDDFNNKFNKLLIR YKAETSLFKAVINYVNKFDPKFRAQFVTNAIDGVTITKVQNTRELRPGTL DDLVVKNKNNVFLQQIQGDTEAVYLPVTAVTNDKWLNTVLVRIPLTKFVR PISVLEAPQQEETQEDGEEMQQGNEDGTQAGQTDETAGSGTPQASTPQTM PNSSQ >MS53_0344 hypothetical protein MKREIKSKYFISVFLTYLICYALALGFFLLINEFSLKQKNSLIDVFTTVS VIFTAVLLLILIFRFGFLKNLFTFFKKNHENTKKLRQEYKSKKLSYEEKQ AYKYLNQQKETKKAAKKPKVKTSNFPFVFIALLSLIITIIVAIISFNL >MS53_0218 putative phase-variable hemagglutinin MTKVQNTRELKPGTLDDLKGNNVFLQQVNGNSSAVYFAVNGVTSQGWLNT FLIRIPLTKFVRPLTEFQAQSPAAPTEEASGDQAQADPQATQMGTQAQSQ >MS53_0065 hypothetical protein MQEIHMKNATKSDENKKLRTECNAFVKQVFLTYEAWNNQLKKQLLNLKFK ESYLKDKNLSQEVHKLEIKIKASGSMIQSILSVMKPENSWIIEKCFLDKN TRNNSLWYKDYFSKSTFYKRKNLAVKEFAQIYFDF